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 Abstract 
Diabetes affects around 13% of the Portuguese population,one in seven patients are at 
high risk of developing diabetic foot. This condition involves several anatomopathological and 
peripheral neurological disorders, which affect the peripheral microcirculation. This might 
have serious consequences such as: ulcers, ischaemia and amputations. The monitoring and 
assessment of the treatments are important to evaluate its progression, and to promptly act 
in case of regression.  
Medical thermography is a noninvasive, nonionising, safe and accurate medical imaging 
method that enables to monitor the temperature distribution on the surface of the skin. This 
information is directly related to the physiology, allowing for real-time assessment, in 
particular microvascular peripheral and autonomic nervous systems. The diabetic foot has 
manifestations in these two systems and is therefore capable of being monitored by the 
proposed technique. 
The present project aims to investigate the use of medical thermography in the 
physiological characterization of patients who already were diagnosed with diabetic foot. 
Moreover, this research should result in the definition of a protocol for the collection and 
analysis of thermographic images of diabetic foot. The results of this project will allow the 
study of diabetic foot disease more extensively, enabling a better knowledge of its 
physiology. The potential of thermography as a tool for folow-up of treatments was 
evaluated. The data collections were perfomed at the Diabetic Foot Clinic at the Hospitalar 
Center of Porto.  
The obtained results can be used as reference for future research studies in the area, the 
proposed methodology can be improved to become used in daily practice, helping clinical 
professionals in the diagnosis and treatment assessment, providing better care and reducing 
the associated costs. 
 
Keywords: diabetic foot; temperature distribution; thermography; ulcers.  
vi 
 
 
 
 
 
 
 
 
vii 
Resumo 
A diabetes afeta cerca de 13% da população portuguesa, cerca de um em cada sete 
doentes com diabetes, está em sério risco de desenvolver pé diabético. Trata-se de uma série 
de alterações anatomopatológicas e neurológicas periféricas que afetam a microcirculação 
periférica e podem ter como consequências graves: úlceras, isquemias e amputações. Pelo 
que a caracterização e monitorização destes sistemas é importante de forma a evitar a sua 
progressão.  
A termografia médica é um método de imagem clínica não invasivo, não ionizante e 
preciso que permite monitorizar a distribuição da temperatura à superfície da pele. Esta 
informação fisiológica pode ser avaliada em tempo real, monitorizando os sistemas 
microvascular periférico e nervoso autónomo. O fenómeno do pé diabético tem manifestações 
nesses dois sistemas e é portanto passível de ser monitorizado por essa técnica.  
Este trabalho de investigação tem como finalidade caracterizar a distribuição da 
temperature à superfície da vista plantar do pé em doentes, bem como o desenvolvimento de 
uma metodologia para a sua monitorização. O trabalho de campo foi realizado na Clínica do 
pé diabético do Centro Hospitalar do Porto. 
Os resultados deste projeto permitirão efetuar estudos de maior dimensão na área da 
patologia do pé diabético, possibilitando conhecer melhor a sua fisiologia, auxiliar no 
diagnóstico e conduzir para um tratamento mais adequado, permitindo a avaliação contínua 
destes tratamentos. Dessa forma contribui para um aumento da qualidade de vida dos 
doentes de pé diabético e permite reduzir de forma eficaz os custos associados à patologia. 
 
Palavras-chave: distribuição de temperatura; pé diabético; termografia; úlceras de pressão. 
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Chapter 1 
 
Introduction 
Diabetes mellitus (DM) is a disease characterized by chronic hyperglycemia with 
disturbances of the metabolism of carbohydrates, fats and proteins resulting from defects in 
insulin secretion, insulin action, or both. There is a worldwide prevalence of disease due to 
aging populations, poor diet, concomitant epidemic of obesity, physical inactivity and 
unhygienic environment [1].  
According to the International Diabetes Federation (IDF), diabetes affects over 371 
million people worldwide, accounting for 8.3% of the world population and continues to 
increase in all countries. In over 50% of people with diabetes it has not been diagnosed, 
pursuing their silent evolution [2]. 
Diabetes in 2012 caused the deaths of 4.8 million people, half of whom were under 60 
years, and it is estimated that in 2030 the number of people with diabetes worldwide will 
reach 552 million, representing an increase of 49% of the population affected by the disease 
[3]. 
A report published in November 2012 by OECD, shows that Portugal is the European Union 
(EU) country with the highest prevalence of diabetes (9.7%), a percentage that exceeds by 
more than three percent the mean of the EU, as shown in Figure 1 [4]. 
 
 
 
 
 
 
 
 
Figure 1 - Distribution of diabetes in many countries worldwide in 2012 [4]. 
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1.1 - Motivation 
Diabetes affects 12.7% of the portuguese population aged between 20 and 79 years, 
which corresponds to an estimated 1.003 million individuals [3]. 
Pathologic changes associated with diabetes are numerous, and the diabetic foot is 
one of the most complicated health problems. Diabetic neuropathy affects changes in 
sensitivity of the feet and is mainly responsible for the appearance of these lesions, 
which are difficult to treat and to prognosis [5]. 
Since diabetes is a condition that affects a large number of population, the costs 
associated with this have great economic impact on the Serviço Nacional de Saúde (SNS) 
and also in the patients self costs. With diabetic population increasing, these costs are 
also increasing proportionally (Figure 2). It is essential to investigate ways to prevent 
and deal with diabetes on a cost-effective manner for the general population and the 
SNS. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Number of sales of Insulins and Oral Antidiabetic in Ambulatory within the SNS in Portugal 
Continental - In Value. (Source: Estatísticas do Medicamento – INFARMED) [3]. 
 
However, there are other costs associated with diabetes, such as loss of income, 
productivity decrease of affected patients and the psychosocial aspect of patients and their 
families, who despite of being intangible are nonetheless important.  
The temperature is a useful indicator of various diseases, the medical use of Thermology 
techniques, such as infrared-based imaging, has potential of use in medicine [6]. 
Infrared thermography is a technique that allows mapping the surface temperature of the 
human body or a region, with the intent of distinguishing areas with different values. Since 
1960, there is an increased understanding of the physiology and thermal relation between the 
skin temperature and blood perfusion. Moreover, the recent advances in the standardization 
of the technique and the advantages of computer aided medical imaging systems have greatly 
improved the reliability of this technology in medicine. In diabetology studies it was 
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demonstrated its value and relevance to the clinical evaluation of peripheral perfusion and 
tissue viability [7]. 
Medical thermography provides functional information that is not provided by any other 
medical imaging methods, and has the great advantage of being non-invasive, non-ionizing 
and accurate, passively capturing the radiant heat emitted from the human body surface 
[8,9]. 
In diabetes, vascular activity in the extremities, especially in the feet, can be indicative 
of autonomous nervous system activity, because the vasomotor function is regulated by 
autonomic fibers of the sympathetic system, and its dysfunction could be associated with 
different patterns of temperature in diabetics [10].  
Complications affecting the lower limbs are the most common manifestations of diabetes 
and infrared imaging can be a useful tool for early identification of those conditions and aid 
to prevent more serious complications, which can lead to amputations, in the most extreme 
situation. 
Due to the severity of problems that may be related to diabetes, and the fact of this 
condition is increasingly affecting more people worldwide, it is necessary to develop 
effective methods to timely detect these situations. Medical thermography presents itself as 
a very credible solution, since it is a painless, non-invasive, non-ionizing and accurate 
method, since it does not cause any harm or discomfort to the patient, and is economically 
affordable [11].  
1.2 - Aim 
The aim of this research is to develop a methodology for characterizing the skin 
temperature of the plantar feet in diabetic patients.  
In addiction to this main goal, the objectives were: 
- Design, implement and assess a methodology for studing surface skin temperature 
of the plantar feet. 
- Characterize the thermal profile of plantar feet in a healthy population. 
- Characterize the temperature profile of plantar feet  in diabetic feet patients. 
- Evaluate quantitative benchmarks to be used as references for future studies. 
- Evaluate the proposed methodology for frequent follow-up of diabetic foot patients, 
through a study case. 
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1.3 - Structure of the Dissertation 
 
This document is further organized in five sections: 
The literature review is divided in two main topics: firstly diabetes is classified and then 
diabetic foot and its main complications are presented. The other topic is thermography, 
where the technique is described, the role of thermoregulation and the relevant studies of 
thermography in the diabetic foot. 
Methodology, the images capture protocol, materials and methods used in this research 
and the analysis methods.  
Results, present the outcomes of all the tests and experiments performed, and also its 
interpretation and more relevant information. 
Discussion, analyzes the significance of findings and the justification of the deviations. 
Conclusion, states the accomplishment of the aim and the proposed future work. 
Figure 3 shows the navigation diagram of this dissertation. 
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Figure 3- Navigation diagram of dissertation. 
1. Introduction 
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Chapter 2 
Literature Review 
In this chapter, the diabetic foot condition is described and characterized. 
Thermography, thermal transfer mechanisms are presented. The role of 
thermoregulation in the human body, microcirculation and thermal imaging. The past studies 
of using Thermology in the diabetic foot condition are also outlined.  
 
 
 
2.1. Diabetes and Diabetic Foot 
2.1.1. Definition and classification of diabetes 
Diabetes mellitus is a set of metabolic diseases characterized by hyperglycemia, which 
results from defective insulin secretion, a flawed insulin action, or both. Chronic 
hyperglycemia is associated with long term damage, dysfunction and failure of several 
organs, namely the eyes, kidneys, nerves, heart and blood vessels. Several pathogenic 
processes are involved in the development of diabetes. These range from the autoimmune 
destruction of pancreatic β-cells, with consequent insulin deficiency, to abnormalities, which 
result in insulin resistance [12]. 
Long term diabetes complications include retinopathy with potential loss of sight, 
nephropathy, which leads to kidney failure, peripheral neuropathy leading to potential feet 
ulcers, amputations and autonomic neuropathy which leads to gastrointestinal, genitourinary 
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and cardiovascular problems, and sexual dysfunction. Diabetic patients are prone to other 
serious illnesses, since they have a high incidence of atherosclerotic peripheral vascular 
disease, cerebral vascular disease, hypertension and an abnormal lipoprotein metabolism.  
Regardless of what causes it, diabetes is associated with a common hormonal defect, 
i.e., insulin deficiency, which can be absolute or relative, according to one's insulin 
resistance. Insufficient insulin has a vital role in metabolic changes associated to diabetes. 
Hyperglycemia, in its turn, plays an important role in disease-related complications [13]. 
Diabetes can be classified according to the following categories: 
 
- Type 1 diabetes: This type of diabetes accommodates around 5-10% of all diabetics, 
and is a consequence of the cell-mediated destruction of pancreatic β-cells, which leads to 
absolute insulin deficiency. The destruction of these cells happens due to various genetic 
predispositions and it is also associated to environmental factors, which have not yet been 
completely defined [12, 13]. 
 
- Type 2 diabetes: Has around 90-95% of all diabetic population, and is characterized by 
insulin resistance and relative insulin deficiency. Most of the patients with this condition do 
not need insulin admission. This type of diabetes frequently remains undiagnosed for years, 
as hyperglycemia develops gradually and the patient does to notice any of the usual diabetes 
symptoms. However, these patients face an increased risk of microvascular and 
macrovascular complications [12].  
 
- Gestational diabetes: For many years, it was characterized as any degree of glucose 
intolerance, which started or was first discovered during pregnancy. Even though, most cases 
can be managed with medication, this definition is applied depending on whether the 
condition persisted after pregnancy and does not exclude the possibility that the 
unrecognized glucose intolerance may have started before or at the same time as the 
pregnancy [12].  
During pregnancy, gestational diabetes requires treatment to optimize maternal blood 
glucose levels to lessen the risk of complications in the infant. The gestation period is 
relatively brief for developing serious complications that cause the appearance of ulcers on 
the feet. However, women who have had gestational diabetes are more prone to develop 
diabetes in the next 10–20 years [14].  
 
- Other specific types: Various types of diabetes are associated with monogenetic 
defects in β-cell function. These forms of diabetes are frequently characterized by 
hyperglycemia at an early age (usually before 25), diminished insulin secretion with little or 
even no effect in insulin action and have an autosomal dominant inheritance pattern. The 
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most common form is associated with chromosome 12 mutations in the hepatic transcription 
factor referred to as a hepatocyte nuclear factor (HNF)-1a. The second type is associated 
with mutations in the glucokinase gene in chromosome 7p. The least common types result 
from transcription-factor mutations, such as HNF-4a, HNF-1b, insulin promoter factor (IPF)-1, 
and NeuroD1. This condition is very rare and was not found information that relates this type 
of diabetes with diabetic foot. 
Diabetes is one of the most common chronic diseases in every country, and its numbers 
continue to increase in size and in importance. This exponential growth has to do with an 
economic and urban development, which leads to lifestyle changes characterized by reduced 
physical activity, increased obesity and an uncontrolled diet [15].  
Along with these factors, the International Diabetes Federation estimates that this 
number will continue to grow worldwide, due to population aging and growth and the high 
prevalence of obesity and a sedentary lifestyle, reaching 522 million people in 2030 [16]. As 
such, diabetes is considered a serious public health problem, due to being a chronic illness 
and affects a large population [17]. 
2.1.2. Definition of diabetic foot 
Diabetic foot is the most common chronic complication in diabetic patients. It affects 
more the patients with type 2 diabetes [18], which has a relation with the duration and 
success of diabetes treatment. Based on epidemiological studies, it is estimated that 25% of 
all diabetics will develop serious health problems related to diabetic foot during their 
lifetime, whilst 5% to 15% of all patients will have their foot or leg amputated [19]. 
 The diabetic foot is characterized through foot lesions as a result of peripheral and/or 
neurologic vascular changes singular to diabetes, known as the triad: neuropathy, peripheral 
vascular disease and infection. If this deterioration is not detected at an early stage, it can 
evolve into gangrene or consequently to limb amputation [20].  
Neuropathy causes loss of sensitivity and pain, which contributes to the existence of 
trauma and ulcerations. The appearance of infection and insufficient irrigation of the lower 
limbs leads to the progression of gangrene. The diabetic patient most of the times does not 
realize there is a lesion until the latter, where it is already in an advanced state, which 
makes treatment more difficult and contributes to the high incidence of amputations in these 
patients [21]. 
The important risk factors include: age, type and time of diagnosis, inadequate glycemia 
control, smoking, alcoholism, obesity, hypertension and lack of hygiene when it comes to 
footcare. Healthcare professionals to assess diabetics' feet regularly, in order to early 
identify the risk factors are very important. That can also be changed through promoting self-
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care, along with a proper metabolic control, which will, in turn, reduce the risk of ulceration 
and amputation [21]. 
2.1.3. Epidemiology 
The "diabetic foot syndrome" encompasses a considerable number of pathological 
conditions, including neuropathy, ischaemia, Charcot's neuroarthropathy, foot ulceration, 
osteomyelitis and amputation [22]. 
Patients with diabetic foot injuries frequently present various diabetes-associated 
complications. As such, there is a need for a multidisciplinary approach, with several 
specialties involved, such as an endocrinologist, a specialized nurse, a podiatrist, a vascular 
surgeon, an orthopedist, a physiatrist and a general practitioner [23]. 
From the pathological conditions present, foot ulcers and amputations are both the most 
common and the most serious complications and are responsible for a significant mortality. 
Foot ulcers precede around 85% of amputations, wich can led to the assumption that a 
success in early detection or adequate treatment of those ulcerations would result in 
reducing the number of amputations [23]. 
The risk of a diabetic patient developing a foot ulcer during their life is around 25% [24]. 
Foot injuries in these patients are the main cause of hospital admission when compared to 
any other long-term diabetes complication, and they also result in an increased morbidity and 
mortality. These lesions occur due to the presence of sensory-motor neuropathy and vascular 
disease [24]. 
Regarding the etiology of foot ulcerations, about 45-60% of ulcers are purely neuropathic, 
about 10% are purely ischemic and 25-45% are mixed (neuroischemic) [25] and happen 
particularly on the sole of the foot in areas subject to high pressure when walking [18]. 
Besides causing pain and morbidity, the diabetic foot has severe economic consequences. 
Costs are reduced by foot ulcer prevention interventions, through strategies that promote 
healing (which shorten the healing period and prevent amputations) [23]. 
2.1.4. Pathophysiology 
Having knowledge of the pathophysiology of the ulceration is essential to provide optimal 
healthcare, since changing the factors that lead to its development allows better healing the 
foot or helps keeping it intact, providing to the patient a completely normal life. 
There is estimation that 15% of all diabetic patients will have a foot ulcer at some point 
in their lives, and about 2 to 3% of all diabetics will develop them every year. Many of these 
ulcers will require prolonged hospitalization to treat subsequent complications, such as 
infection or gangrene. [26-28]. 
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As Figure 4 shows the relation between the most important factors that lead to a 
vulnerable high risk of diabetic foot and contribute to the appearance of an ulcera, which 
are: neuropathy, macroangiopathy, medial artery calcification or Mönckeberg arteriosclerosis 
and diabetic microangiopathy. When one or more of these factors is present, the existence of 
a triggering factor which acts on the vulnerable foot will lead to the formation of an ulcer or 
necrosis [26-28].  
 
 
 
 NEUROPATHY                     MICROANGIOPATHY                 MACROANGIOPATHY 
       Sensory Motor Autonomic                                                      
                                                                                                       Blood flow reduction 
                                           
 
 
 
 
 
Increase plantar pressure 
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TRIGGER FACTORS: 
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Figure 4- Mechanism of appearance of the ulcer [27]. 
 
2.1.4.1. Neuropathy and peripheral vascular disease 
 
Since neuropathy and peripheral vascular disease are the etiological factors most related 
to the appearance of foot ulcers, it is necessary to understand these two causal mechanisms.  
Peripheral polyneuropathy (sensory, motor and autonomic) derives from axon terminal 
degeneration, where the intensity varies proportional with the size. Since the largest size 
exists in both inferior limbs, neuropathy is a bilateral complication [23]. 
Diabetic distal neuropathy can affect the three components of the nervous system: sensory, 
motor or autonomic, and all of them contribute to the development of foot ulcers. 
Consequently, somatic (sensory-motor) and autonomic fibers are also affected. The smallest 
nervous fibers do suffer changes, which causes the loss of pain and temperature sensations.     
Deformation 
Overload unnoticed 
Ulcer 
Extension of lesion, necrosis 
Ischaemia 
Functional   
Structural 
 
Diabetic foot risk 
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Subsequently, the largest nervous fibers will also be affected, which will leads to a decreased 
superficial sensation perception [26]. 
Neuropathy can have two different classifications:  
 
- Sensory-motor neuropathy, consists of a gradual loss of tactile and pain sensitivity, 
which causes feet to be vulnerable to trauma, called "loss of protective feeling" [28]. The 
latter is subdivided in two classes: acute sensory neuropathy, which is rare and follows 
periods of inadequate control or sudden change in metabolic control, and chronic sensory-
motor neuropathy, which is the most common type of neuropathy. Instability and loss of 
balance have been increasingly recognized as possible manifestations of peripheral chronic 
polyneuropathy, secondary to proprioceptive disturbances and possibly abnormalities in 
sensitive muscle function. This instability may result in repeated minor traumas or falls and 
late complications, such as Charcot's neuroarthropathy, which consists of consequential 
repeated traumas in the foot. These changes are also clearly related to the appearance of 
ulcers [26]. 
About 50% of all patients present symptoms, such as: pain, dysesthesia, paresthesia, very 
warm skin and numbness. However, since about half the patients can be asymptomatic, it can 
only be diagnosed during a medical exam or when the patient presents a painless foot ulcer 
[29].  
This loss of sensitivity is very serious and may lead to major injuries since, for example, a 
diabetic person with loss of protective feeling may no longer feel the discomfort of the 
repeated pressure of a tight shoe or the pain of a pointy or sharp object on the floor. It also 
leads to foot intrinsic muscle atrophy, causing an imbalance between flexor and extensor 
muscles, triggering osteoarticular deformities. The latter will change the pressure points in 
the sole of the foot, leading to overburdening and to a skin reaction with local hyperkeratosis 
(callus), which, with continuous walking, will evolve into ulceration [28]. 
 
- Autonomic neuropathy, in turn, consists of an autonomic nervous system injury, 
namely of the sympathetic nerves, leading to loss of vascular tonus1, causing vasodilation 
with an increase in arteriovenous communication and, as a consequence, the direct passage 
of blood from the arterial to the venous network, decreasing tissue nutrition. This 
phenomenon leads to hypohidrosis, a skin illness that causes reduction or absence of sweat 
secretion due to the low activity of the sympathetic system, which causes the dry skin, 
culminating in the appearance of fissures and changes in the growth and matrix of nails, 
which much like chronic ulcers, are important entrance points for infections [28,29]. 
                                                 
1 Vascular tonus is the degree of sustained constriction of the vascular system, which regulates the peripheral 
vascular resistance and contributes to the charge against which the heart must pump (Post-Charge) [30]. 
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Vascular disease is responsible for more than 70% of deaths of patients with type 2 
Diabetes [29]. Diabetic peripheral vascular affection is divided in microangiopathy, 
Mönckeberg arteriosclerosis and macroangiopathy caused by atherosclerosis. 
Diabetes is associated with an increased risk of peripheral vascular disease. However, this 
is not frequently the primary etiology of diabetic foot problems, such as ulceration or 
amputation. It is, nevertheless, implied in the altered response to infections and in the 
healing process, being present in almost 50% of all amputated patients [26, 29]. 
This pathogenic entity is, therefore, more important in the persistence and evolution of 
diabetic foot ulcers then in its appearance. Foot infection and/or ulceration entail the need 
to increase blood supply to damaged tissue. If the patient has peripheral vascular disease, it 
may not be possible to answer that need (whether due to ischaemia or because vessels are 
unable to dilate), causing more tissue damage and causing the infection progression [26]. 
Given this, its presence worsens the prognosis for these patients, increasing the risk of 
amputation. Thus, it is of vital importance to identify and treat the co-existing peripheral 
vascular disease.  Vascular disease is frequent in diabetics, but it is only threatening to the 
limb if there is a skin lesion. Adequate tissue perfusion is vital for the ulcers to heal 
correctly. Whenever an ulcer does not heal there is a suspicion of arterial failure, which can 
cause more severe complications [26, 31].  
2.1.5. Innervation and vascularization of foot 
Diabetic foot is the set of neurological and vascular conditions affecting the feet of 
patients with diabetes, like aforementioned. So it is important understanding the role of 
autonomous nervous system and the microvascular system on the overall risk of ulceration in 
diabetic patients. 
Pathological changes in the feet can occur in the muscles (muscles, tendons or 
ligaments), bone or vascular (veins, arteries, vessels and microvessels). Vascularization 
region of the ankles and feet are usually more susceptible to such changes given its 
complexity. Thus, conditions that affect the circulation area, such as diabetes, tend to slow 
down the blood return, which ultimately lead to swollen feet, pain and accumulation of 
toxins in the region, in addition to the propensity to wounds and delayed cell regeneration 
[32]. 
The innervation of the foot (figure 5A) is provided by the following nerves: superiorly by 
the deep and superficial peroneal nerves; Inferiorly by the medial and lateral plantar nerves; 
Medially by the saphenous nerve, which extends distally to the head of the 1st metatarsal; 
Laterally by the sural nerve, including the heel part, and this by calcaneal branches of the 
tibial and sural nerves [33]. 
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The different zones shown in the figure are also referred to dermatomes, which are areas 
of the skin that are innervated by nerve fibers that originate from a single dorsal nerve 
ganglion. Each dermatome is named according to the spinal nerve that innervates it. 
Correspondence between the skin and the nervous system dermatome is used to help locate 
the degree of neurological deficit [34]. 
Foot vascularization (figure 5B) is carried out by the following metatarsal arteries distally 
to the crevices of the fingers, being united with the plantar arch, and plantar metatarsal 
arteries perforating branches; Arcuate artery that is disposed laterally through the bases of 
the four lateral metatarsal passing deep to the tendons of the extensor muscles, thus 
achieving the lateral aspect of the forefoot; Medial artery of the foot corresponding to 
continuation of anterior tibial artery, and a major source of blood supply to the front part of 
the foot; Lateral tarsal artery, a branch of the dorsal artery of the foot laterally and follows a 
curved path under the short extender fingers with the aim of supplying this muscle and tarsal 
joints and the underlying [34]. 
 
 
 
Figure 5 - Location of plantar nerves (A) [35]; Location of plantar arteries (B)[36]. 
  2.1.6. Diagnosis 
As previously mentioned, the ulceration of the diabetic foot is associated with peripheral 
vascular disease and peripheral neuropathy, which are frequently combined. However, 
individuals who have a high ulceration risk can be easily identified through a careful foot 
examination. Education and periodical follow-ups are also indicated in these cases [23]. 
When it comes to the physical examination, the American Diabetes Association (ADA) 
approves a few different tests to identify sensory loss in the sole of the foot due to 
neuropathy. These tests are:  
1 - Sural nerve 
2- Saphenous nerve 
3- Lateral plantar nerve 
4- Medial plantar nerve 
5- Medial calcaneal branch 
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a) Semmes Weinstein monofilament test, illustrated in Figure 6, in which the incapacity 
to feel the necessary pressure to bend the 10g monofilament when tested in various areas of 
the foot is compatible with sensory neuropathy [37]. 
 
Figure 6 - Evaluation of the diabetic foot using the Semmes Weinstein [37]. 
b) Reflex hammer test. Deep sensation can be assessed through the Achilles tendon reflex 
test by using the reflex hammer, and absence of reflex is connected to an increased 
ulceration risk. 
c) Testing with a 128 Hz tuning fork and with a biothesiometer, by which we can assess 
vibration perception. An abnormal response can be defined when the patient loses vibration 
perception, but the latter is still detected by the examiner [37, 23]. 
All these tests are used to determine the risk of ulceration but the monofilament test, 
due to its simplicity and low cost, is considered to be the best choice [37]. 
To assess peripheral vascular disease, palpation of pedis and posterior tibial arterial 
pulses is recommended, characterizing them as present or absent. For patients with signs and 
symptoms of vascular disease or an absent pulse, an ankle-brachial index (ABI) measurement 
must be performed, and a vascular surgeon referral must be considered.   
ABI is an accurate way of assessing arterial perfusion, where you can check systolic 
arterial blood pressure in the leg (posterior tibial pulse) and in the arm, measuring the ratio 
between them. While the patient is resting, an index is considered normal when below a rate 
of 0.9 to 1.3. A decreased index suggests a vascular disease, considered light to moderate 
when the index is 0.4 to 0.9 and serious when below 0.4 [37]. 
 Some clinical features that distinguish the type of foot ulcers are summarized in Table 1. 
 
Table 1– Clinical features that distinguish neuropathic and vascular foot ulcers [38]. 
 
 
 
 
Neuropathic ulcers Vascular ulcers 
Painless Painful 
Located at points of high pressure Often located at the extremities 
Warm foot Cool ischaemic foot 
Bounding foot pulses Absent foot pulses 
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These methods are used daily in the care of patients with diabetic foot, however can be a 
little subjective. Depend on the person who executes them, and can be lengthy. Thus arises 
the need to implement new methods of detection and monitoring diabetic foot more efficient 
and objectives, as for example the thermography. 
 
2.1.7. Prevention 
The best form of prevention is, unquestionably, health education. Diabetics must be 
advised to reduce risk factors, such as smoking, reducing fat intake, stabilizing or reducing 
weight and having an optimal glycemia control, among others [39]. 
Diagnostic exams must be performed at least once a year, and healthcare professionals 
must educate patients about self-monitoring, i.e., the daily inspection of their feet, since the 
absence of symptoms does not mean that their feet are healthy. During this inspection, it is 
advisable to pay special attention to color, temperature, joint mobility and nail problems.  
Since footwear is one of the main causes of ulceration, patients should not wear shoes 
that are too tight or too loose, and they should be inspected beforehand. Pathologies 
associated with calluses, nails and skin must be treated regularly. It is also highly 
recommended to maintain good foot hygiene and to use moisturizes to avoid the appearance 
of fissures [40]. 
Consequently, the best way to prevent diabetic foot complications is to educate the 
patients, so that they can check their feet every day and consult a professional whenever any 
anomality is present. This will ensure an early diagnosis and an effective treatment [39, 40]. 
 
 
2.2. Thermography  
2.2.1.Thermology: principles and procedures 
Thermology is the field of Physics that studies heat, and the manifestations of the types 
of energy, which produce temperature variations (heating, cooling, or even the change in 
physical state that derives from these two variations) [41]. 
Thermology studies the way by which heat can be exchanged between bodies, as well as 
the characteristics of each heat transfer process, which consist of four different mechanisms: 
conduction, convection, evaporation and radiation [41]. 
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In order to understand the role of thermology, it is firstly necessary to distinguish 
between temperature and heat. Heat is tangible and consists on thermal energy in motion, 
i.e., it is energy that is in constant motion, always being transferred from one hotter body to 
a cooler one. Temperature, on the other hand, is a measure of the status of molecule 
agitation. The temperature is proportionally related with the molecules agitation [41,42]. 
Medical thermography consists on documenting the distribution of thermal radiation 
emitted at the surface of the skin, by using infrared imaging. Both the skin’s galvanic 
impedance and the vasomotor and sudomotor responses can be assessed by studying the way 
skin responds in medical infrared images, i.e. through infrared thermography. This technique 
involves no contact and no form of energy is transmitted to the body, which makes it a 
complementary diagnostic and treatment-assessing test with great potential [43]. 
There are four mechanisms of heat loss: conduction, convection, evaporation and 
radiation.  
- Conduction is the transfer of heat from one solid object to another when in direct 
contact with it [53]. 
- Convection is based on heat transfer by the movement of a fluid (liquid or gaseous) in 
the body. Blood, heated by the visceral and the somatic metabolism, is convected by the 
vascular system and transferred to the inside of the body, and then to low temperature 
areas, thus representing the largest heat transfer mechanism inside the body. 
- Evaporation is the conversion of water into vapor, by means of thermal energy.  This 
process occurs throughout the surface of the body, and mainly in the respiratory system. This 
mechanism is of very little importance in the thermal image when the individual is in balance 
with his environment [53]. 
- Radiation represents the largest heat loss mechanism in the human body, responsible 
for 60% of its total loss. Thermal energy is converted into electromagnetic radiant energy, 
which is emitted by the body in the infrared spectrum band. Central blood temperature is 
brought to the skin's vascular network, where thermal energy is converted into radiant energy 
and transmitted to the environment. This radiation is detected through infrared cameras 
[45,53]. 
 
2.2.2. Thermography and its application 
The biomedical use for thermography has increased over the last fifty years. Since this is 
a completely non-invasive technique, its use has been helpful in terms of medical research as 
a sensitive complimentary diagnosis method for different clinical and experimental levels 
[44]. 
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Thermography offers valuable information on the temperature differences of different 
parts of the human body surfaces. It enables to monitor the nervous system, metabolic or 
vascular disturbances, skin cancer, pain syndromes, soft tissue damage, virus infections and 
others by comparing thermal changes and differences. Since infection and inflammation can 
appear in any part of the human body, causing temperature changes, thermography is 
therefore a valuable tool for repetitive monitoring which will not harm the patients. 
Since the camera used for temperature detection only receives natural thermal energy 
emitted by the body, and no harmful energy is used, this technique can be used continuously 
in various tests over time [44, 45]. 
 
2.2.3. Thermoregulation and heat transfer mechanisms 
Clinical information obtained by thermography is not directly based on changes in 
metabolic activity and heat production. It is based on heat distribution in the body and the 
regulation of that heat loss, especially at the surface of the skin. Metabolic heat is brought 
from the inside of the body, by the vena cava and the larger veins where it is mixed and 
distributed by the aorta and its branches [46]. 
The human body has a good homeostatic control mechanism for body conditions, 
including temperature, pH and others. Temperature is a useful parameter to assess the body 
health condition. The core temperature of our body is usually kept at 36.8 ± 0.6°C and, if the 
temperature in a certain area is higher or lower, and therefore not normal, it becomes an 
indicator of a possible problem, such as infection or necrosis [47].  
The skin works as an interface between body and environment. It is possible to measure 
the temperature along the surface of the skin. The balance between the body and 
surrounding environment made through thermoregulation. Blood flow play an important role 
in this process, any changes in it induces changes in skin temperature [48]. 
Human skin blood flow responses to body heating and cooling are essential to the normal 
processes of physiological thermoregulation. In humans, reflex sympathetic innervation of the 
cutaneous circulation has two branches: a sympathetic noradrenergic vasoconstrictor system, 
and a non-noradrenergic active vasodilator system. Noradrenergic vasoconstrictor nerves are 
tonically active in normothermic environments and increase their activity during cold 
exposure, releasing both norepinephrine and cotransmitters (including neuropeptide Y) to 
decrease skin blood flow. The active vasodilator system in human skin does not exhibit 
resting tone and is only activated during increases in body temperature, such as those 
brought about by heat exposure or exercise [49]. 
Figure 7 illustrates the vasodilation and vasoconstricition processes. In vasodilation, the 
hypothalamus sends nerve impulses via parasympathetic nervous system to blood vessels near 
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the skin. Smooth muscle in vessel walls relaxes, but ‘shunt vessel’ constricts so more blood 
goes to the surface. In vasoconstriction the sympathetic nerve impulses to blood vessels near 
the skin. Smooth muscle in vessel wall contracts so less blood flow, shunt vessel relaxes so 
less blood flows to the surface capillaries. Less heat lost by radiation is thus typical of 
vasoconstriction [50]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7- Illustration of vasodilation and vasoconstriction processes, respectively [50]. 
There are other mechanisms that help maintain body temperature, sudoresis and muscle 
contraction. The sudoresis, which is the act of producing and releasing sweat, begins when 
the core body temperature is above 37°C. This mechanism is regulated via stimulation of the 
sweat glands by cholinergic sympathetic nerves and sometimes in situations such as exercise 
or stress by high concentrations of epinephrine and norepinephrine [51]. 
Muscle contraction is also an important source of thermal energy - muscle thermogenesis. 
This can be stimulated by the cerebral cortex or involuntarily by the hypothalamus. The 
posterior hypothalamus modulates the degree of inhibition of the activity of neurons in the 
spinal cord.  
The decrease of inhibition of the previous neurons (promoted by a decrease in core body 
temperature below the set value) at an early stage leads to increased muscle tone, and 
subsequently repetitive contractions occur.  
The rapid involuntary skeletal muscle contraction may result in a 4-fold increase in heat 
production, of 2 times the oxygen uptake and the 6 times the metabolic rate [51]. 
Thus, the thermoregulatory control of human skin blood flow is vital to the maintenance 
of normal body temperatures during challenges to thermal homeostasis.  
Skin temperature in a given area depends on that area's blood supply and on the thermal 
conductivity of subcutaneous structures. Cutaneous microcirculation is mainly controlled by 
sympathetic activity and is, for that reason, frequently used experimentally as a measure of 
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sympathetic activity, since arterioles, particularly the ones in the skin and fingertips, only 
have sympathetic adrenergic constrictor nerves [52]. The peripheral and central nervous 
system (CNS) receptors detect minimal thermal variations and change the peripheral blood 
flow in order to maintain a constant central temperature, adjusting the vascular network in 
dissipating the excess heat at the surface of the skin. It is the distribution of blood in that 
superficial vascular network that is observed by thermography [54]. 
Thermography is an imaging technique that maps the distribution of body surface thermal 
radiation into images, providing a real-time microcirculatory and autonomous nervous 
dynamic physiological assessment of cutaneous surface. Thermography allows quantitative 
and qualitative mapping of superficial temperature, which can be related to different 
pathological conditions and blood flow [53]. 
 
2.2.4.Infrared radiation and thermography  
Electromagnetic radiation is continuously emitted from all substances because of the 
molecular and atomic agitation associated in their internal energy. In equilibrium, the 
internal energy is associated to the temperature. An object can be characterized by its 
capacity of absorbing or emitting electromagnetic radiation. 
Electromagnetic radiation can be classified according to its wavelength and frequency 
[55]. The electromagnetic spectrum includes gamma rays, X-rays, ultraviolet, visible, 
infrared, microwaves, and radio waves. The difference between these different types of 
radiation is their wavelength and frequency. Wavelength increases, and frequency (as well as 
energy and temperature) decreases from gamma rays to radio waves [55]. 
Infrared waves have wavelengths longer than visible and shorter than microwaves, and 
have frequencies lower than visible and higher than microwaves.  
Infrared radiation (IR) encompasses wavelengths that go from 0.76 to 1000 µm, divided 
into short, medium and long wave, as illustrated in Figure 8. 
Human body emissions, which are usually measured for diagnostic purposes, take up a 
narrow band of wavelengths that go from 8 to 13.5 µm, with this area being mentioned as the 
long wave infrared [56].  
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Figure 8- Wavelength of infrared radiation, divided into short, medium and longe waves [57]. 
 
Computerized infrared thermography is a method that allows for the viewing, 
documentation and measurement of infrared rays along the human body. According to Stefan-
Boltzmann, this emission is proportional to the temperature of the skin and is directly related 
to the blood flow inside the blood vessels [58]. The Stefan-Boltzman law of radiation states 
that the radiant output increases to the fourth power of its temperature. The conduction and 
convection components increase only in direct proportion with the temperature change. In 
other words, as the temperature of a heat source is increased, a much greater percentage of 
the total energy output is converted into radiant [59]. 
Thermograms are IR-generated images, and are used for medical diagnostic purposes 
based on the fact that many pathological processes in the human organs manifest themselves 
as local changes in heat production, as well as changes to the blood flow pattern of affected 
tissues [58]. Modern infrared technology has opened new perspectives, especially when it 
comes to the use of thermal images to map the temperature of the surface of the body with a 
remote sensing camera, which allows for a quick and effective complimentary diagnostic and 
treatment assessment information [44]. 
 
2.2.5. Previous Studies 
Infrared thermal imaging of the skin has been used for about five decades to monitor the 
temperature distribution of human skin [45]. The human body is an efficient thermal system, 
and we are entirely dependent on the ability of the body to self-regulate human body 
temperature.  
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Since diabetes is a disease with high prevalence worldwide, in the last decades many 
studies have been developed, and researches showed that there is a relationship between 
increased skin temperature and foot complications in diabetes. It also contributed for a 
greater understanding of termal physiology and the relationship between skin temperature 
and blood perfusion [60].  
Abnormalities such as malignancies, inflammation, and infection cause localized increases 
in temperature which shown as hot spots or asymmetrical patterns in a thermogram. 
Therefore thermography is a powerful detector of the location of problems that affect a 
patient's physiology [45]. 
One of the first studies in this area was in 1967, in which Brånemark [61] compared feet 
of 16 diabetes patients with and without manifest vascular complications using infrared 
thermography. This technique revealed that all 16 diabetics had abnormalities in the emission 
patterns from feet, and he concluded that thermography was a useful technique for the study 
of circulation and metabolism in diabetes.  
Lavery et al. [62] performed a long study in which 173 individuals with a previous history 
of diabetic foot ulceration participated. The main goal was to evaluate the effectiveness of a 
temperature monitoring instrument to reduce the incidence of foot ulcers in patients with 
diabetes who have a high risk for lower extremity complications. 
All the participants all were instructed to self-monitor their feet by measuring 
temperatures using a thermometer and register all the values. The feet was divided in 
different regions of interest (hallux; first, third, and fifth metatarsal heads; midfoot; and 
heel), and if they verified a difference of temperature of 2.2°C they should call a nurse. The 
results shown that over 50% of patients did call the nurse, and 8% of them went on to develop 
ulcers. Thus concluding that if patients are instructed to monitor their feet at home, they 
may simply prevent serious conditions such as the appearance of ulcers that can result in 
amputation later.  
Armstrong et al. [63], made a similar approach that have the purpose of evaluate the 
effectiveness of home temperature monitoring to reduce the incidence of foot ulcers in high-
risk patients with diabetes. This study involved 225 participants with diabetes at high risk of 
develop ulcers and they were instructed to inspect their feet daily and measure the 
temperatures of six regions and record their findings. If patients verified a temperature 
difference higher than 2.2°C, they should contact the study coordinator.  
The results of this study has shown that 8.4% ulcerated over the study period. Those 
patients who ulcerated had a temperature difference that was 4.8 times greater at the local 
of ulceration in the week before the ulcers appeared there did a random seven-consecutive-
day sample of 50 other subjects who did not ulcerate.  
Once again, this study showed that the temperature is an indicator of possible foot 
problems and that self-monitoring, after the individuals are trained to take care of your feet, 
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is a good way to keep a tighter surveillance for possible development of ulcers in the diabetic 
foot.  
In 2008, "The Glamorgan Protocol" [64] was defined, which is a project that is based on 
the creation of an atlas of the normal distribution of skin temperature, in order to fill gaps in 
knowledge of the distribution of skin temperature in healthy subjects. This atlas is a set of 
views of body positions and regions of interest of normal infrared images of healthy subjects, 
and when this protocol is strictly applied for image recording and evaluation, increases the 
reproducibilty of findings from thermal images.  
The guideline [64] defined 24 body positions and 90 regions of interest in order to 
construct a clinical database of reference thermograms. The improved reproducibility of body 
positions and location of regions of interest has been shown to have a marked influence on 
both the accuracy and precision of temperature measurements obtained from thermal images 
[65]. 
The assessment and posterior eradication of diabetic foot ulcers is a complex and 
challenging process. The underlying pathophysiology lead to a chronic inflammatory stage, 
which may prevent appropriate healing, therefore Bharara et al. in 2010 [66], used 
quantitative thermography to provide a useful numerical índex (WII – Wound Inflammatory 
Index) to assess wound healing. In this study, the authors propose a new tool for quantifying 
wound conditions, which includes the thermal features and wound size, both of which may 
play a key role in determining the duration of would healing. It provided a standardized 
methodology using thermal imaging for calculating a thermal index (TI) supported with a case 
report from assessment of a diabetic foot ulcer. Typically, when using infrared thermography, 
the anatomical surfaces of the foot were examined to identify potential hot/cold areas where 
inflammation or circulatory increase/loss is occurring, respectively. But, in this case infrared 
and visible imaging were used to determine the shape, area, curvature, and eccentricity 
characteristics, showing a new potential of infrared thermography.  
In studies related to body temperatures one of the parameters to be considered is the 
thermal symmetry value of human body. This important fact has been studied and proven by 
Ring [67] in a study of the lower leg. 
Vardasca, et al. [68] based on the standard for recording and evaluation “Glamorgan 
Protocol” aforementioned, confirmed and defined that the highest thermal symmetry value 
for the upper and lower extremities was of 0.5±0.3  ºC.  
Such as infrared thermal imaging is being increasingly utilized in multiple studies of the 
body and different medical conditions, the data on the thermal symmetry (or the lack of it) 
provides valuable information for the health professionals in assessing pathological states.   
A computational analysis application [68] was developed to standardise and optimise the 
time of analysis. This tool performs thermal image morphing based on anatomical landmarks 
preserving the temperature values associated with the regions of interest (ROI) and generates 
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statistics about mean temperature, standard deviation of those ROI's. Thermal Symmetry 
assumptions can therefore be made with higher confidence when assessing abnormalities in 
specific pathologic states.  
Balbinot, et al. [69] evaluated plantar thermography sensitivity and specificity in 
diagnosing diabetic polyneuropathy using cardiac tests as a reference standard because 
autonomic small fibers are affected first by this disease. Two thermographic variables were 
studied: the thermal recovery index and the interdigital anisothermal technique. 
The plantar infrared image was recorded at baseline followed by the provocative 
maneuvers using the cold stress test. After 10 minutes, a new plantar infrared image was 
recorded to evaluate the thermal recovery index. To calculate the recovery index, the mean 
temperatures of 10 regions of interest with similar dimensions were used: the hallux, 1st, 
3rd, and 5th metatarsal heads and heel on both soles. Balbinot proved that plantar 
thermography was useful in the early diagnosis of diabetic neuropathy, particularly the small 
and autonomic fibers that are commonly associated with a sub-clinical condition.  
Jaap J. van Netten et. Al [70], have led studies of the diabetic foot using thermography 
to another level. Although several previous studies have demonstrated how thermography can 
be useful to detect and monitor diabetic foot complications, however, it still not being used 
in common medical practice.  
The purpose of this research was to explore the first steps in the applicability of high-
resolution infrared thermal imaging for noninvasive automated detection of signs of diabetic 
foot disease. Their main goal is to develop an intelligent telemedicine monitoring system that 
can be deployed for frequent examination of the patient’s feet to timely and automatically 
detect signs of diabetic foot complications, such as ulcers. 
In this study [70] thermal images of 15 participants, divided in 3 groups of 5 people each 
(diabetic patients without signs of foot complications, patients with local signs of foot 
complications and patients with diffuse complications) were collected and processed (using 
Matlab). The results shows that there is no diferences in mean temperature higher than 1.5°C 
between the ipsilateral and the contralateral foot in the firt group of patients, for the second 
group the results were similar and for the last group, it was found that mean temperature 
differences were higher than 3°C.   
This is a very recent study [70], but the authors had promising results and showed that it 
is possible to detect signs of diabetic foot complications with an algorithm based on 
parameters that can be captured and analyzed with a high-resolution infrared camera.  
Peregrina-Barreto et. Al [71], proposed a methodology that obtains quantitative 
temperature differences in the plantar area of the diabetic foot for detecting ulceration 
risks. Such methodology is based on the angiosome concept and imaging processing 
techniques. A methodology was presented aiming at providing quantitative information about 
abnormal temperature differences in symmetric regions between feet and inside of the same 
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foot. For this, the plantar area was divided into four main regions (angiosomes) and the 
temperatures inside those regions were grouped in classes according to a color similitude 
criterion.  
An index (ET) based on the relation between the class with larger area and its adjacent 
classes was proposed in order to estimate a representative temperature for each angiosome. 
A second analysis was performed to study the temperatures inside the angiosomes with the 
aim of detecting the presence of small abnormal areas (hot areas). This estimator was 
capable to detect the presence of abnormal regions in the initial phase that, for their smaller 
area, were not detected by the estimator ETD. Through this way, it was possible to analyze 
the whole plantar area by providing quantitative information to determine the presence of 
regions in possible risk of ulceration.  
In summary, without any doubt, temperature is a crucial parameter for the physiological 
study of diabetic foot. All this studies proved that thermography has great potential and can 
bring reliable information to help specialists in early detection of the ulceration risks and to 
monitor treatments. 
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Chapter 3 
Methodology 
In this chapter, the sample characterization, the used materials, the capture protocol 
and the analysis approach are described. 
3.1. Sample and capture images protocol 
This empirical study was based on a convenient sample. The sample consisted in 90 
participants of two groups of participants: a group of diabetic patients of the Diabetic Foot 
Clinic at the Hospitalar Center of Porto (CHP) and a control group constituted by healthy 
volunteers, who did not have diabetes or any other disease or pathological complication. 
 The criteria for inclusion for this sample were diabetics patients of CHP and healthy 
participants without diabetes. The criteria for exclusion for healthy participants was having 
history of any injuries/surgeries in the foot. For diabetic participants were excluded from the 
study samples individuals with amputated foot regions. 
The sample was constituted by men and women without ethnic distinction, aged between 
21 and 87 years. Inflammation was provided about the research and volunteers were invited 
to participate. Their participation in this study was voluntary, and they may quit at any time 
without prejudice to them. 
The total sample consists of healthy individuals and diabetics, who were divided into 
three groups. The reason for this division is that it is not possible to apply a stimulus across 
the sample of diabetic patients, due the logistic and short time of medical appointment. Thus 
the groups that constitute the total sample of 90 people, including healthy and diabetic 
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individuals to which a stimulus was applied and a third group of diabetic individuals without a 
a stimulus application. 
Before data collection, ethical approval was requested and obtained from the ethics 
comitte of the CHP (Appendix A), enforcing that all participants were treated fairly and 
equaly treated and all the available resources were used with responsability. 
On the day of the assessment, it was requested from the participant to sign an informed 
consent form (Appendix B) and to fill in a questionnaire (Appendix C), followed by a period of 
thermal acclimatization to the examination room and image acquisition. A document with 
information about thermography procedure was also given to the volunteers (Appendix D). It 
is noteworthy that this investigation was completetly safe and painless, it did not presented 
any risk to the individual, and all data collected was confidential.  
Figure 9 shows the sample distribution, the total sample consisted of 90 participants, 
including healthy (with stimulus) elements (N = 40), diabetics (with stimulus) elements (N = 
14) and diabetics (without stimulus) elements (N=36). 
 
 
 
 
Figure 9- Participants distribution, divided in three groups. 
 
Table 2 shows the distribution of healthy (with stimulus), diabetics (with stimulus) and 
diabetics (without stimulus) participants by gender. 
 
Table 2- Distribution of participants by gender. 
 
 
 
 
 
N=40 
N=14 
N=36 
Sample 
Healthy (with stimulus) 
Diabetics (with stimulus) 
Diabetics (without stimulus) 
Participants Female [N] Male [N] 
Healthy (with stimulus) 24 16 
Diabetics (with stimulus) 8 6 
Diabetics (without stimulus) 13 23 
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Table 3 shows  the distribution of healthy (with stimulus), diabetics (with stimulus) and 
diabetics (without stimulus) participants by age interval. Healthy participants have ages 
between 18 and 39, and diabetic participants are a older sample with ages between 18 and 
≥70 years. 
 
Table 3- Distribution of participants by interval of age. 
 
 
 
 
 
 
 
 
 
 
 
Table 4 shows the distribution of healthy (with stimulus), diabetics (with stimulus) and 
diabetics (without stimulus) participants by glicemia interval. Both groups of healthy and 
diabetic participants have a higher frequency in the glicemia interval ≥125 mg/dl.  
Table 4- Distribution of participants of interval of glicemia. 
 
 
 
 
 
 
 
 
Table 5 shows the distribution of healthy (with stimulus), diabetics (with stimulus) and 
diabetics (without stimulus) participants by Body Mass Index (BMI) interval. This value was 
calculated from the values of the weight and height of participants through the equation 1: 
 
    
           
          
  (Equation 1) 
Healthy participants have a BMI between <18.5 and 30, and diabetic participants have a 
larger range with BMI between 18.5 and ≥35. 
 
Interval of  
Age (years) 
Healthy 
 (with stimulus) 
Diabetics  
(with stimulus) 
Diabetics 
 (without stimulus) 
18 - 29 39 0 1 
30 - 39 1 1 2 
40 - 49 0 1 0 
50 - 59 0 3 6 
60 - 69 0 3 9 
≥70 0 6 18 
Interval of 
glicemia (mg/dl) 
Healthy 
 (with stimulus) 
Diabetics  
(with stimulus) 
Diabetics 
 (without stimulus) 
<100 11 0 8 
100 - 125 4 4 11 
≥125 25 10 17 
  
 
 
30 
N=30 
N=2 
N=18 
Type of Ulcer 
Neuropathic 
Ischaemic 
Neuroischaemic 
 
Table 5- Distribution of participants by BMI interval. 
 
 
 
 
 
 
 
 
 
 
Figures 10 and 11 illustrate the distribution of diabetic participants by diabetes type and 
ulcer type associated with the diabetic foot, respectively. 
 
 
Figure 10- Distribution of diabetic participants by diabetes type. 
 
 
 
 
 
 
 
 
 
 
Figure 11- Frequency of diabetic participants by ulcer type. 
N=26 N=24 
Type of Diabetes 
Type I 
Type II 
Interval of  
BMI (kg/m2) 
Healthy 
 (with stimulus) 
Diabetics  
(with stimulus) 
Diabetics 
 (without stimulus) 
<18.5 1 0 0 
18.5 - 25 32 6 18 
25 - 30 7 4 11 
30 - 35 0 3 4 
≥35 0 1 3 
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3.2. Evaluation instruments 
3.2.1. FLIR Thermacam Researcher Pro 
ThermaCAM Researcher Pro is a robust real-time digital storage, measurement, and 
analysis software. This tool digitally stores and retrieves static and sequences of infrared 
images and provides detailed, precision analysis and measurement tools for capturing, 
recording, and studying extremely high speed thermal events. This was the software used to 
capture and analyze infrared images throughout this study, and is illustrated in figure 10 [72]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12- Illustration of ThermaCAM Researcher Pro software for an analysis of foot thermal image. 
 
3.2.2. Blood glucose test 
Once this study is related to diabetes, it was important to measure the glycemic index of 
the volunteers. For such a glucometer was used to measure glicemia, and these values were 
grouped into three categories: >100 mg/dl, 100-125 mg/dl and ≥125 mg/dl. Blood glucose 
levels of diabetic individuals were all measured in the fasting state. Glicemia of healthy 
individuals was not measured in the fasting state due to the different availability of the 
participants. 
3.3. Materials   
The equipment used for data collection were: 
- FLIR A325 camera, to capture the thermographic images. This thermal camera has an 
integrated spatial resolution of 320x240 pixels, which has sensors that measures 
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A – Computer  
B – Thermograhic camera 
C – Tripod to support the camera 
Controlled environment 
temperatures ranging from -20°C to +120°C. Its thermal sensitive is of 50mK and has an 
accuracy ± 2% of the overall reading [73]. 
- ThermaCAM Researcher  Pro 2.10, a Windows-based infrared software package for 
capturing, recording, and analyzing thermal images. 
- Tripod to install and position the camera and the level of patients; 
- Fan Tristar VE-5955 (45W), for apply a cold stimulus to the patient; 
- Sensor Testo 175 H1, for measuring temperature and humidity of the room; 
- Glucometer eBsensor NIST standard SRM965 to measure glucose volunteers (precision of 
0.007 mg/g); 
- Lancets eBsensor; 
- Microsoft Excel 2010, to organize data for subsequent statistical analysis;  
- SPSS v21.0 (Statistical Package for the Social Sciences) to statistical processing. 
Some of this materials and their position for thermal images capture are illustrated in 
Figure 13. 
 
 
 
 
 
 
Figure 13- Illustration of equipment for capturing thermographic images. The temperature and 
humidity of the room should be maintained within comfortable limits, and the camera must be 
positioned perpendicular to the observation surface at a distance of 80-150 cm from the feet of the 
volunteer to minimize geometric errors in temperature measurement. [74] 
3.4. Procedures  
3.4.1. Data collection procedure 
Data collection procedure was accomplished according to a thermal protocol (Appendix 
C). Thermal images were collected in a temperature-controlled room, and the body region 
being observed, the plantar feet, were bare and free of any metal ornament or other object 
type, which ensures that the thermal radiation emitted naturally from the human body, is not 
absorbed or scattered by any of the objects.  
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To enable the temperature of the individuals remains balanced with the ambient 
temperature, about 22±1°C it was necessary that before start capturing images of the 
volunteers, remained in the room for 10 min. So that the body remains at equilibrium with 
the environment temperature and relative humidity (<50%) and air flow (<5m/s) that have 
been kept under control.  
Thermographic images were captured in three stages:  
1) Following the individual to be climatized at room conditions (10min);  
2) After application of a cold stimulus (applied by a fan for 2 min);  
3) 5 minutes after the capture of the second image. 
The plantar foot capturing method is illustrated in Figure 14. In this study a cold stimulus 
was applied, with the intention of causing an imbalance of temperature in order to measure 
the response time and maximize physiologic response.  
This way the images were captured at 3 different stages to try to understand how 
physiological processes respond and outlines the temperature profiles of healthy individuals 
and diabetic individuals within a certain period of time. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14-Illustration of thermal imaging over the three stages. 
  
Since the measurement tool used for this study is the temperature of a region of the 
human body, it was important to record the values of humidity and temperature in the 
environment were thermal images were collected. The environment that surround us affects 
our body balance, and therefore these two factors are important to consider. 
Table 6 presents the data characterizing the sample relative to the Mean and Standard 
Deviation of humidity and temperature by study group. 
 
 
10 min 2 min 5 min 
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N1- Sural region 
N2- Lateral region 
N3- Calcaneal region 
N4+N5 – Medial region 
N6- Saphenous region 
 
 
 
Table 6 - Mean and Standard Deviation of humidity and temperature by Group (Diabetics Vs Healthy). 
 
 
3.4.2. Data analysis procedure 
3.4.2.1.Selection of Regions of interest (ROIs) 
To analyze the temperature of the foot over the 3 stages, it were selected 15 regions of 
interest on foot (ROIs). This ROIs were based in the anatomy (Section 2.1.5), the ANS are 
based in the feet dermatomes location and the VS are based in the main perfurated blood 
vessels location. Images were then analyzed in two ways:  
According the autonomic nervous system (ANS) with 6 ROIs (Figure 15), and the vascular 
system (VS) with 9 ROIs (Figure 16). For all ROIs their absolute mean temperature was 
measured. 
This measurements of ANS and VS ROIs were made with ThermaCAM Researcher Pro 
software for all participants. Its thermal symmetry for each ROIs was also calculated through 
the equation 2: 
Thermal symmetry = |Temp. Left foot – Temp. Right foot| (Equation 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 - ROIs of autonomic nervous system (pallet rain). 
 
 
Healthy 
participants 
Diabetic 
participants 
Humidity 45.06 (±4.57) 67.87 (±6.28) 
Temperature 23.32 (±0.80) 24.97 (±1.41) 
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Figure 16– Regions of interest of vascular system (pallet rain). 
 
3.4.2.2 Statistical analysis 
 
For the appropriate presentation of the data obtained, tables were used, with their 
statistical data, which will be followed by the respective analysis. Data were obtained using 
descriptive and inferential statistics, using SPSS-21.0 (Statistical Package for Social Sciences) 
software.  
The Kolmogorov-Smirnov (K-S) test was used to verify if the sample follows the normal 
distribution. Kolmogorov-Smirnov test is used to verify the adjustment to normality of a 
variable of ordinal level or higher. The normal distribution is an essential requirement for the 
application of parametric tests. Although consulting histogram can give indications on the 
normal (or not) by a set of data, that assessment is often subjective, being advisable to 
perform the K-S test. A sample had a normal distribution if p value >0.05 [75] In order to 
verify the relationship between variables, if the sample follows the normal distribution the 
parametric test, student t-test should be used. In case of the sample do not follow the 
normal distribution, non-parametric tests such as Kruskal-Wallis and U Mann-Whitney are the 
recommended. Significance level was set at p<0.05. [75] 
Student t-test is used to compare mean relative a certain variable, considering two 
groups of subjects, that is, when there are two experimental conditions involving different 
subjects. It is not necessary that the groups have exactly the same size, but it is desirable 
that there is a great imbalance. [75]  
The Kruskal-Wallis H test is a rank-based nonparametric test that can be used to 
determine if there are statistically significant differences between two or more groups of an 
independent variable on a continuous or ordinal dependent variable.[76]  The Mann-Whitney 
U test is also used to compare differences between two independent groups when the 
dependent variable is either ordinal or continuous, but not normally distributed. [77]  
V1- First metatarsal region 
V2- Second metatarsal region  
V3- Third metatarsal region 
V4 – Forth metatarsal region 
V5- Fifth metatarsal region 
V6- Arcuate region 
V7- Medial region 
V8- Lateral region 
V9- Calcaneal region 
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Chapter 4 
Results 
In this chapter, the thermal experimental results arising from the implementation of the 
methodology mentioned in Chapter 3 will be detailed.  
 
 
4.1- Characterization of sample temperature 
 
Regarding the sample themal characterization2 in diabetic foot, thermographic images 
were collected in accordance with the capture protocol and procedure described in 
methodology chapter. Images were collected of total sample divided into three groups. And 
this data collection was made across three stages: 
 
-  40 Healthy participants (with stimulus): images collected in 3 stages 
-  14 Diabetics (with stimulus):  images collected in 3 stages 
-  36 Diabetics (without stimulus): images collected in 1 stage 
 
The images collected were analyzed according to the ROIs for autonomic nervous system 
(ANS) and vascular system (VS) (defined in chapter 3). 
 
 
 
                                                 
2 All temperatures presented in this study were measured in Celsius degrees (°C).  
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4.1.1. Sample temperature for 1st stage 
In Table 7 and 8 are summarized the mean temperatures and standard deviation for 
autonomous nervous system and vascular system, respectively. This data refers to the mean 
temperatures for the first stage, i.e., without any intervention, and they were presented into 
two groups, healthy and diabetic participants (with and without stimulus together). 
Through the observation of these data it can be verified that the healthy participants 
have mean temperature of ANS and VS lower than diabetic participants.  
Healthy participants have a minimum mean temperature for the ANS of 26.07 ºC in region 
N1R and maximum of 28.01 ºC in region N6R. Diabetic participants have a minimum mean 
temperature for the ANS of 28.99 ºC in region N1L and maximum of 30.42 ºC in region N6R. 
 
Table 7 – Temperature distribution in ROIs of the ANS by participant type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the VS, healthy individuals have a minimum mean temperature of 23.71 ºC in region 
V2R and maximum of 28.43 ºC in region V7R. Diabetic individuals have a minimum mean 
temperature of 28.13 ºC in region V2L and maximum of 30.58 ºC in region V7R. 
 
 
 
 
 
 
ROIs of ANS 
Healthy 
participants 
Diabetic 
participants 
N1L 26.30 ± 1.22 28.99 ± 1.83 
N1R 26.07 ± 1.27 29.29 ± 1.82 
N1S 0.40 ± 0.28 1.04 ± 1.00 
N2L 26.61 ± 1.48 29.56 ± 1.82 
N2R 26.60 ± 1.60 29.97 ± 1.97 
N2S 0.42 ± 0.39 1.32 ± 1.10 
N3L 26.08 ± 1.33 29.42 ± 2.13 
N3R 26.23 ± 1.40 29.49 ± 1.97 
N3S 0.59 ± 0.51 1.15 ± 1.00 
N4+5L 26.56 ± 1.67 29.93 ± 1.98 
N4+5R 26.55 ± 1.77 30.16 ± 1.94 
N4+5S 0.43 ± 0.39 1.07 ± 0.67 
N6L 27.99 ± 1.41  30.24 ± 1.75 
N6R 28.01 ± 1.44 30.42 ± 1.66 
N6S 0.48 ± 0.50 0.84 ± 0.83 
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Table 8 – Temperature distribution in ROIs of the VS by participant type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The K-S test for the presented samples had a p value < 0.05, which means that the 
samples did not follow the normal distribution, so for any further statistical analysis non-
parametric methods will be used.  
Analysis of significance through the Mann-Whitney test to verify the relationship between 
healthy and diabetic participants considering the mean temperatures of the ROIs of the ANS 
and VS are present in table 8 and 9. 
In Table 9, it is verified that healthy and diabetic individuals present statistical 
significance (p<0.05) for all regions of the ANS.  
 
 
 
ROIs of VS 
Healthy 
participants 
Diabetic 
participants 
V1L 24.75 ± 2.19 29.12 ± 4.76 
V1R 24.79 ± 2.32 28.41 ± 6.27 
V1S 0.60 ± 0.56 1.05 ± 0.89 
V2L 23.83 ±1.99 28.13 ± 6.20 
V2R 23.71 ± 1.75 29.36 ± 2.19 
V2S 0.56 ± 0.71 3.39 ± 7.00 
V3L 23.86 ± 1.58 28.90 ± 2.19 
V3R 23.80 ± 1.68 29.37 ± 2.21 
V3S 0.39 ± 0.42 1.38 ± 1.25 
V4L 24.05 ± 1.56 28.26 ± 4.64 
V4R 24.04 ± 1.78 29.40 ± 2.24 
V4S 0.42 ± 0.31 1.58 ± 1.42 
V5L 24.62 ± 1.87 28.86 ± 2.15 
V5R 24.47 ± 1.86 29.30 ± 2.12 
V5S 0.51 ± 0.50 1.20 ± 1.00 
V6L 26.70 ± 1.79 29.89 ± 2.20 
V6R 26.55 ± 1.90 30.52 ± 2.32 
V6S 0.48 ± 0.40 1.39 ± 1.06 
V7L 28.25 ± 1.51 30.33 ± 1.71 
V7R 28.43 ± 1.32 30.58 ± 1.60 
V7S 0.50 ± 0.85 0.86 ± 0.89 
V8L 27.56 ± 1.52 29.81 ± 1.91 
V8R 27.67 ± 1.56 30.18 ± 1.83 
V8S 0.50 ± 0.42 1.25 ± 0.99 
V9L 26.00 ± 1.52 29.37 ± 2.22 
V9R 26.08 ± 1.54 29.47 ± 2.03 
V9S 0.63 ± 0.52 1.07 ± 0.94 
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Table 9- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for ANS ROIs 
temperatures in all partipants in 1st stage. 
 
 
 
In Table 10, it is verified that healthy and diabetic individuals present statistical 
significance (p<0.05) for all regions of the VS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of ANS 
U W Z p 
N1L 206.50 1026.50 -6.45 0.00 
N1R 143.50 963.50 -6.96 0.00 
N1S 489.50 1309.50 -4.16 0.00 
N2L 245.50 1065.50 -6.13 0.00 
N2R 194.50 1014.50 -6.54 0.00 
N2S 321.00 1141.00 -5.53 0.00 
N3L 176.50 996.50 -6.69 0.00 
N3R 174.50 994.50 -6.71 0.00 
N3S 526.00 1346.00 -3.86 0.00 
N4+5L 209.00 1029.00 -6.42 0.00 
N4+5R 180.50 1000.50 -6.66 0.00 
N4+5S 337.00 1157.00 -5.39 0.00 
N6L 303.00 1123.00 -5.66 0.00 
N6R 276.50 1096.50 -5.88 0.00 
N6S 532.50 1352.50 -3.81 0.00 
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Table 10- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for VS ROIs 
temperatures in all partipants in 1st stage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of VS 
U W Z p 
V1L 174.00 994.00 -6.71 0.00 
V1R 240.50 1060.50 -6.17 0.00 
V1S 588.00 1408.00 -3.35 0.00 
V2L 163.00 983.00 -6.80 0.00 
V2R 43.50 863.50 -7.77 0.00 
V2S 380.00 1200.00 -5.04 0.00 
V3L 59.50 879.50 -7.64 0.00 
V3R 53.50 873.50 -7.69 0.00 
V3S 378.00 1198.00 -5.07 0.00 
V4L 113.50 933.50 -7.20 0.00 
V4R 66.00 886.00 -7.59 0.00 
V4S 424.00 1244.00 -4.69 0.00 
V5L 147.00 967.00 -6.93 0.00 
V5R 90.00 910.00 -7.39 0.00 
V5S 377.00 1197.00 -5.07 0.00 
V6L 268.50 1088.50 -5.94 0.00 
V6R 203.50 1023.50 -6.47 0.00 
V6S 375.00 1195.00 -5.09 0.00 
V7L 351.00 1171.00 -5.27 0.00 
V7R 304.00 1124.00 -5.65 0.00 
V7S 508.50 1328.50 -4.00 0.00 
V8L 348.50 1168.50 -5.29 0.00 
V8R 314.00 1134.00 -5.57 0.00 
V8S 429.50 1249.50 -4.64 0.00 
V9L 207.50 1027.50 -6.44 0.00 
V9R 188.50 1008.50 -6.59 0.00 
V9S 589.00 1409.00 -3.35 0.00 
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4.1.2. Profile temperature for 2nd stage 
In Table 11 and 12 there are summarized the mean temperatures and standard deviation 
for autonomic nervous system and vascular system, respectively. This data refers to the mean 
temperatures for the second stage, i.e., after a cold stimulus applied with a fan during 2 
minutes. It was presented into two groups, healthy and diabetic participants (with stimulus). 
Through the observation of these tables it can be verified that the healthy participants 
have mean temperature for ANS and VS ROIs lower than the diabetic participants.  
Healthy participants have a minimum mean temperature for ANS of 24.93 ºC in region N3L 
and maximum of 26.56 ºC in region N6R. Diabetic participants have a minimum mean 
temperature for ANS of 28.64 ºC in region N3R and maximum of 29.84 ºC in region N6L. 
 
 
 
 
Table 11- Temperature distribution in ROIs of the ANS by participants’ type. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In VS, the healthy individuals have a minimum mean temperature of 22.91 ºC in region 
V2R and maximum of 26.86 ºC in region V7R. Diabetic individuals have a minimum mean 
temperature of 27.27 ºC in region V2L and maximum of 30.00 ºC in region V7L. 
 
 
 
ROIs of ANS 
Healthy 
participants 
Diabetic 
participants 
N1L 25.42 ± 0.95 28.78 ± 2.52 
N1R 25.32  ± 1.08 28.77 ± 2.26 
N1S 0.33  ± 0.24 0.92 ± 0.85 
N2L 25.52  ± 1.06 29.47 ± 2.7 
N2R 25.71  ± 1.46 29.52 ± 2.27 
N2S 0.46  ± 0.54 1.24 ± 0.87 
N3L 24.93  ± 1.01 29.03 ± 2.79 
N3R 25.11  ± 1.15 28.64 ± 2.44 
N3S 0.49  ± 0.41 1.07 ± 0.83 
N4+5L 25.32  ± 1.13 29.76 ± 2.6 
N4+5R 25.37  ± 1.21 29.44 ± 2.42 
N4+5S 0.30  ± 0.24 1.15 ± 0.58 
N6L 26.54  ± 0.87 29.84 ± 2.31 
N6R 26.56  ± 1.04 29.52 ± 2.07 
N6S 0.39  ± 0.43 1.12 ± 0.58 
  
 
 
43 
Table 12- Temperature distribution in ROIs of the VS by participants’ type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of significance to verify the relationship between healthy and diabetic 
participants through the Mann-Whitney test considering the mean temperatures in the ROIs of 
autonomous nervous and vascular systems to verify the independency of healthy and diabetics 
participants was shown in tables A and B in Appendix E. 
In both tables, it can be verified that healthy and diabetic individuals present statistical 
significance (p<0.05) for all regions in the ANS and VS.  
 
 
 
 
 
ROIs of VS 
Healthy 
participants 
Diabetic 
participants 
V1L 23.70 ± 1.59 29.09 ± 2.71 
V1R 23.74 ± 1.58 28.87 ± 2.70 
V1S 0.48 ± 0.53 1.08 ± 0.66 
V2L 22.93 ± 1.14 27.27 ± 8.15 
V2R 22.91 ± 1.12 28.47 ± 2.70 
V2S 0.32 ± 0.27 3.21 ± 6.56 
V3L 22.97 ± 1.12 28.59 ± 2.53 
V3R 22.92 ± 1.13 28.62 ± 2.41 
V3S 0.25 ± 0.18 1.31 ± 0.99 
V4L 23.17 ± 1.10 28.66 ± 2.82 
V4R 23.16 ± 1.27 28.78 ± 2.50 
V4S 0.28 ± 0.28 1.61 ± 1.30 
V5L 23.58 ± 1.39 28.59 ±2.63 
V5R 23.58 ± 1.50 28.87 ± 2.41 
V5S 0.33 ± 0.31 1.06 ± 0.82 
V6L 25.53 ± 1.33 30.08 ± 2.83 
V6R 25.49 ± 1.56 30.02 ± 2.56 
V6S 0.36 ± 0.27 1.33 ± 1.01 
V7L 26.74 ± 0.98 30.00 ± 2.18 
V7R 26.86 ± 0.98 29.62 ± 1.86 
V7S 0.34 ± 0.47 1.14 ± 0.63 
V8L 26.27 ± 1.08 29.78 ± 2.50 
V8R 26.44 ± 1.27 29.66 ± 2.07 
V8S 0.43 ± 0.33 1.26 ± 0,76 
V9L 24.94 ± 1.11 29.13 ± 2.79 
V9R 25.07 ± 1.29 28.75 ± 2.46 
V9S 0.49 ± 0.39 1.06 ± 0.73 
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4.1.3. Profile temperature for 3rd stage 
In Table 13 and 14 there are summarized the mean temperatures and standard deviation 
of autonomous nervous system and vascular system regions, respectively. This data refers to 
the mean temperatures for the third stage, i.e., after a period of 5 minutes after cold 
provocation to analyse the recovery response. It was presented into two groups, healthy and 
diabetic participants (with stimulus). 
Through the observation of these tables it can be verified that the healthy participants 
have mean temperature of ANS and VS lower than diabetic participants.  
Healthy participants have a minimum mean temperature for ANS of 24.86 ºC in region N3L 
and maximum of 27.01 ºC in region N6L. Diabetic individuals have a minimum mean 
temperature for ANS of 28.92 ºC in region N1L and maximum of 30.39 ºC in region N6L. 
 
 
Table 13- Temperature distribution in ROIs of the ANS by participants’ type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the VS, healthy individuals have a minimum mean temperature of 22.98 ºC in region 
V2L and maximum of 27.22 ºC in region V7R. Diabetic participants have a minimum mean 
temperature of 27.88 ºC in region V2L and maximum of 30.51 ºC in region V6L. 
 
 
 
 
 
ROIs of ANS 
Healthy 
participants 
Diabetic 
participants 
N1L 25.47 ± 1.02 28.92 ± 2.70 
N1R 25.24 ± 1.21 29.02 ± 2.43 
N1S 0.43 ± 0.47 1.06 ± 0.94 
N2L 25.64 ± 1.24 29.73 ± 2.87 
N2R 25.74 ± 1.49 29.89 ± 2.42 
N2S 0.39 ± 0.32 1.31 ± 1.16 
N3L 24.86 ± 1.15 29.46 ± 3.06 
N3R 25.07 ± 1.44 29.11 ± 2.66 
N3S 0.54 ± 0.58 1.22 ± 1.05 
N4+5L 25.54 ± 1.51 30.13 ± 2.78 
N4+5R 25.35 ± 2.75 29.86 ± 2.50 
N4+5S 0.76 ± 2.00 1.10 ± 0.74 
N6L 27.01 ± 1.05 30.39 ± 2.46 
N6R 26.94 ± 1.21 30.12 ± 2.09 
N6S 0.29 ± 0.32 0.98 ± 0.59 
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Table 14- Temperature distribution in ROIs of the VS by participants’ type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of significance through the Mann-Whitney test considering mean temperatures of 
ROIs for autonomous nervous and vascular systems for testing the independence between 
healthy and diabetics participants was shown in table C and D in Appendix F. 
In both tables, it is verified that healthy and diabetic individuals present statistical 
significance (p<0.05) of independence for all regions of the ANS and VS.  
The Figures 17 illustrates thermal images from a healthy individual and Figure 18 a 
diabetic individual over the three stages of the study, respectively. In these thermal images 
it is very visible a variation of feet temperature during data collection. 
 
 
 
ROIs of VS 
Healthy 
participants 
Diabetic 
participants 
V1L 23.93 ± 2.63 29.45 ± 2.96 
V1R 24.27 ± 2.93 29.18 ± 2.89 
V1S 0.72 ± 1.40 1.24 ± 1.11 
V2L 22.98 ± 1.92 27.88 ± 8.43 
V2R 23.18 ± 1.91 28.79 ± 2.68 
V2S 0.64 ± 1.34 3.56 ± 6.69 
V3L 23.06 ± 1.73 29.02 ± 2.94 
V3R 23.13 ± 1.89 28.94 ± 2.57 
V3S 0.35 ± 0.39 1.53 ± 1.46 
V4L 23.39 ± 1.88 29.03 ± 3.05 
V4R 23.36 ± 2.08 29.20 ± 2.60 
V4S 0.40 ± 0.54 1.91 ± 1.50 
V5L 23.78 ± 1.96 29.00 ± 2.97 
V5R 23.76 ± 2.17 29.19 ± 2.53 
V5S 0.48 ± 0.63 1.24 ± 1.24 
V6L 25.63 ± 1.57 30.51 ± 3.03 
V6R 25.65 ± 2.02 30.36 ± 2.63 
V6S 0.54 ± 0.55 1.49 ± 1.11 
V7L 27.19 ± 1.18 30.48 ± 2.31 
V7R 27.22 ± 1.31 30.19 ± 1.90 
V7S 0.44 ± 0.70 0.97 ± 0.74 
V8L 26.46 ± 1.23 30.05 ± 2.69 
V8R 26.57 ± 1.40 30.06 ± 2.22 
V8S 0.44 ± 0.32 1.27 ± 1.05 
V9L 24.86 ± 1.28 29.50 ± 3.11 
V9R 25.03 ± 1.34 29.24 ± 2.74 
V9S 0.49 ± 0.37 1.17 ± 1.03 
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Figure 17– Thermal images of the feet of a healthy individual over the three stages. 
 
Figure 18– Thermal images of the feet of a diabetic individual over the three stages. 
 
Thermal Images of the feet were collected in three stages in order to understand the 
thermophysiology in a healthy foot and a diabetic foot when suffering a bodily imbalance. 
This physiological response may be measurable, and the ROIs mean temperature of both 
systems are presented in figures 19 and 20 for a healthy and diabetic feet.  
In the Figure 19, for the ANS, it is observed that for healthy individuals there was a 
decrease of 1.1°C in the second stage and an increase of 0.1°C after the third stage. Diabetic 
individuals experienced a decrease of 0.2°C in the second stage and an increase of 0.4°C in 
the third stage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19- Variation of the mean temperature of ROIs of autonomous nervous system throughout the 
three stages of healthy and diabetic feet. 
26.7 
25.6 25.7 
29.7 
29.3 
29.7 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
Stage 1 Stage 2 Stage 3 
A
N
S
 R
O
Is
 M
e
a
n
 T
e
m
p
e
ra
tu
re
 
Profile Temperature for ANS 
Healthy foot 
Diabetic foot 
  
 
 
47 
In Figure 20, for the VS, it is observed that for healthy individuals there was a decrease of 
1.1°C in the second stage and an increase of 0.2°C after the third stage. Diabetic individuals 
experienced a decrease of 0.4°C in the second stage and an increase of 0.4°C in the third 
stage. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20- Variation of the mean temperature of ROIs of vascular system throughout the three stages of 
a healthy and diabetic feet. 
 
 
       For a better understanding of the impact of the stimulus and the responsiveness of the 
temperature recovery, the temperature difference for the various ROIs was calculated. These 
values were calculated through the difference between mean temperature ROIs of Stage 2 
and Stage 1, and the difference between Stage 3 and Stage 1, for healthy and diabetic 
individuals. Table 15 shows the different values for ANS ROIs, where the values of minimal 
and maximal difference for healthy and diabetic indviduals are highlighted. 
      And in Table 16 there are presented the values of difference between stages for VS ROIs, 
where the values of minimal and maximal difference for healthy and diabetic indviduals are 
highlighted. 
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Table 15- Difference of mean temperatures of ANS ROIs for healthy and diabetic participants. 
  
 
Table 16- Difference of mean temperatures of VS ROIs for healthy and diabetic participants. 
 Healthy 
Participants 
Healthy 
Participants 
Diabetic 
Participants 
Diabetic 
Participants 
 
ROIs of ANS 
S2-S1 S3-S1 S2-S1 S3-S1 
N1L -0.88 -0.83 -0.21 -0.07 
N1R -0.75 -0.83 -0.52 -0.27 
N2L -1.09 -0.97 -0.09 0.17 
N2R -0.89 -0.86 -0.45 -0.08 
N3L -1.15 -1.22 -0.39 0.04 
N3R -1.12 -1.16 -0.85 -0.38 
N4+5L -1.24 -1.02 -0.17 0.2 
N4+5R -1.18 -1.2 -0.72 -0.3 
N6L -1.45 -0.98 -0.4 0.15 
N6R -1.45 -1.07 -0.9 -0.3 
 Healthy 
Participants 
Healthy 
Participants 
Diabetic 
Participants 
Diabetic 
Participants 
 
ROIs of ANS 
S2-S1 S3-S1 S2-S1 S3-S1 
V1L -1.05 -0.82 -0.03 0.33 
V1R -1.05 -0.52 0.46 0.77 
V2L -0.9 -0.85 -0.86 -0.25 
V2R -0.8 -0.53 -0.89 -0.57 
V3L -0.89 -0.8 -0.31 0.12 
V3R -0.88 -0.67 -0.75 -0.43 
V4L -0.88 -0.66 0.4 0.77 
V4R -0.88 -0.68 -0.62 -0.2 
V5L -1.04 -0.84 -0.27 0.14 
V5R -0.89 -0.71 -0.43 -0.11 
V6L -1.17 -1.07 0.19 0.62 
V6R -1.06 -0.9 -0.5 -0.16 
V7L -1.51 -1.06 -0.33 0.15 
V7R -1.57 -1.21 -0.96 -0.39 
V8L -1.29 -1.1 -0.03 0.24 
V8R -1.23 -1.1 -0.52 -0.12 
V9L -1.06 -1.14 -0.24 0.13 
V9R -1.01 -1.05 -0.72 -0.23 
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4.2. Relation between diabetic foot temperature and 
diabetic foot ulcer 
 
Diabetic participants had different types of feet ulcer. These can be denominated 
neuropathic, ischaemic, and neuroischaemic depending on their origin. Therefore, because of 
this variability in pathology of diabetic foot, it was studied if there is any relationship 
between foot ROIs temperature and type of ulcer. Three cases were studied: 
a) Ulcer neuropathic vs ulcer ischaemic 
b) Ulcer neuropathic vs ulcer neuroischaemic 
c) Ulcer ischaemic vs ulcer neuroischaemic 
4.2.1. Ulcer neuropathic vs ulcer ischaemic 
Analysis of the Independence between diabetics participants with neuropathic and 
ischaemic ulcers through the Mann-Whitney test considering the mean temperatures in ROIs 
for autonomic nervous and vascular systems is shown in table 17 and 18 respectively. 
In table 17, it is verified that diabetic participants with neuropathic and ischaemic ulcers 
do not present statistical significance (p>0.05) of Independence for any region of ANS. 
 
 
Table 17- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for ANS ROIs 
temperatures of partipants with neuropathic and ischaemic ulcers. 
 
 
ROIs of ANS U W Z p 
N1L 30.00 33.00 0.00 1.00 
N1R 29.00 494.00 -0.08 0.94 
N1S 28.00 31.00 -0.16 0.88 
N2L 26.00 29.00 -0.31 0.76 
N2R 25.00 490.00 -0.39 0.70 
N2S 16.00 481.00 -1.09 0.28 
N3L 30.00 33.00 0.00 1.00 
N3R 23.00 26.00 -0.55 0.59 
N3S 18.00 483.00 -0.94 0.35 
N4+5L 24.00 27.00 -0.47 0.64 
N4+5R 29.50 494.50 -0.04 0.97 
N4+5S 18.00 483.00 -0.94 0.35 
N6L 24.00 27.00 -0.47 0.64 
N6R 28.00 31.00 -0.16 0.88 
N6S 24.50 489.50 -0.43 0.67 
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In table 18, it is verified that diabetic participants with neuropathic and ischaemic ulcers 
only present statistical significance (p<0.05) of Independence in one region, V3S, of vascular 
system. 
 
Table 18- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for VS ROIs 
temperatures of partipants with neuropathic and ischaemic ulcers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.2. Ulcer neuropathic vs ulcer neuroischaemic 
 
Analysis of significance of the Independence between diabetics participants with 
neuropathic and neuroischaemic ulcers through through the Mann-Whitney test considering 
 
ROIs of VS 
U W Z p 
V1L 19.00 22.00 -0.86 0.39 
V1R 29.00 494.00 -0.08 0.94 
V1S 26.00 491.00 -0.31 0.76 
V2L 27.00 30.00 -0.23 0.82 
V2R 30.00 33.00 0.00 1.00 
V2S 20.00 485.00 -0.78 0.44 
V3L 13.00 16.00 -1.32 0.19 
V3R 26.50 491.50 -0.27 0.79 
V3S 2.00 467.00 -2.18 0.03 
V4L 12.00 15.00 -1.40 0.16 
V4R 26.00 491.00 -0.31 0.76 
V4S 3.00 468.00 -2.11 0.04 
V5L 17.00 20.00 -1.01 0.31 
V5R 23.50 26.50 -0.51 0.61 
V5S 21.00 486.00 -0.70 0.48 
V6L 24.00 27.00 -0.47 0.64 
V6R 23.00 488.00 -0.55 0.59 
V6S 11.00 476.00 -1.48 0.14 
V7L 24.00 27.00 -0.47 0.64 
V7R 26.50 29.50 -0.27 0.79 
V7S 29.50 32.50 -0.04 0.97 
V8L 28.00 31.00 -0.16 0.88 
V8R 26.00 491.00 -0.31 0.76 
V8S 29.50 32.50 -0.04 0.97 
V9L 29.50 494.50 -0.04 0.97 
V9R 25.00 28.00 -0.39 0.70 
V9S 20.00 485.00 -0.78 0.44 
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the mean temperatures of ROIs for autonomic nervous and vascular systems is shown tables E 
and F of Appendix G. 
In this tables E and F of Appendix G, it can be verified that diabetic participants with 
neuropathic and neuroischaemic ulcers do not present statistical significance (p>0.05) of 
independence for any region of the ANS and the VS. 
 
4.2.3. Ulcer ischaemic vs ulcer neuroischaemic 
 
Analysis of significance of the Independence between diabetics participants with 
ischaemic and neuroischaemic ulcers through through the Mann-Whitney test considering the 
mean temperatures in ROIs for autonomous nervous and vascular systems are shown in tables 
G and H of APPENDIX H. 
In this tables G and H of Appendix H, it can be verified that diabetic individuals with 
ischaemic and neuroischaemic ulcers do not present statistical significance (p>0.05) of 
independence for any region of the ANS and the VS. 
The figure 21 illutrates the thermal and visible images of feet with neuropathic, 
ischaemic and neuroischaemic ulcers, where can be visualized their differences of 
temperature distribution.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21– Thermal and visual images of a neuropathic, ischaemic and neuroischaemic ulcers. 
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4.3. Relation between foot temperature and characteristics 
of individuals 
 
To study the relation between the diferente population characteristics and the type of 
participants, the following comparisons were performed: 
a) Different type of diabetes 
b) Healthy and diabetic individuals with different glicemia interval 
c) Healthy and diabetic individuals with different BMI classification 
d) Healthy and diabetic individuals with different age group 
Tested whether these variables have or not statistical significance when analyzed for the 
mean temperature in ROIs of autonomic nervous and vascular system.  
4.3.1. Different type of diabetes 
In the group of participants with diabetes, there are individuals who differ in the type of 
diabetes (type 1 and type 2), it was investigated if there is any relationship between 
temperature of the various feet ROIs for ANS and VS and type of diabetes. 
Analysis of significance of the relation between mean temperatures in ROIs of ANS and VS 
with type of diabetes through Mann-Whitney test is shown in table 19 and 20. 
In table 19, it can be verified that individuals with diabetes type 1 or type 2 present 
statistical significance (p<0.05) for region N4+5R of the ANS. 
 
Table 19 - Mann Whitney test for different type of diabetes in the ANS. 
 
ROIs of ANS 
U W Z p 
N1L 265.50 565.50 -0.69 0.49 
N1R 201.00 501.00 -1.98 0.05 
N1S 274.00 574.00 -0.52 0.60 
N2L 281.00 581.00 -0.38 0.70 
N2R 209.00 509.00 -1.82 0.07 
N2S 243.50 543.50 -1.13 0.26 
N3L 265.50 565.50 -0.69 0.49 
N3R 212.50 512.50 -1.75 0.08 
N3S 255.50 555.50 -0.89 0.37 
N4+5L 299.50 624.50 -0.01 0.99 
N4+5R 190.50 490.50 -2.19 0.03 
N4+5S 241.50 541.50 -1.17 0.24 
N6L 294.00 594.00 -0.12 0.90 
N6R 210.50 510.50 -1.79 0.07 
N6S 283.50 583.50 -0.33 0.74 
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In table 20, it can be verified that individuals with diabetes type 1 or type 2 present 
statistical significance (p<0.05) for region V1R of the VS. 
 
 
Table 20- Mann Whitney test for different type of diabetes in the VS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of VS 
U W Z p 
V1L 286.00 611.00 -0.28 0.78 
V1R 196.50 496.50 -2.07 0.04 
V1S 294.50 619.50 -0.11 0.91 
V2L 272.50 597.50 -0.55 0.58 
V2R 227.50 527.50 -1.45 0.15 
V2S 272.50 572.50 -0.55 0.58 
V3L 285.50 585.50 -0.29 0.77 
V3R 200.50 500.50 -1.99 0.05 
V3S 208.00 508.00 -1.84 0.07 
V4L 281.00 581.00 -0.38 0.70 
V4R 212.50 512.50 -1.75 0.08 
V4S 219.50 519.50 -1.61 0.11 
V5L 279.00 579.00 -0.42 0.67 
V5R 238.00 538.00 -1.24 0.22 
V5S 226.00 526.00 -1.48 0.14 
V6L 279.50 579.50 -0.41 0.68 
V6R 207.50 507.50 -1.85 0.06 
V6S 234.50 534.50 -1.31 0.19 
V7L 285.50 585.50 -0.29 0.77 
V7R 229.50 529.50 -1.41 0.16 
V7S 256.50 556.50 -0.87 0.38 
V8L 283.00 583.00 -0.34 0.73 
V8R 217.00 517.00 -1.66 0.10 
V8S 300.00 600.00 0.00 1.00 
V9L 264.50 564.50 -0.71 0.48 
V9R 205.00 505.00 -1.90 0.06 
V9S 226.50 526.50 -1.47 0.14 
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4.3.2. Different glicemia interval 
 
 
Since this study approaches a condition associated with diabetes, it was measured the 
glycemic index of participants, and depending on its value, they were included in a glicemia 
classification (>100, 100-124 and ≥125 mg/dl).  
Analysis of significance of the glicemia intervals through the Kruskal-Wallis test based in 
the comparison of the mean temperature in ROIs of ANS and VS is data shown in Tables 21 
and 22. 
In table 21, it can be verified that the healthy participants with different glucose value 
do not present any significance statistical (p>0.05) of independence for regions of ANS. And 
the diabetics participants have only presented statistical significance for the region N4+5R of 
the ANS.  
 
Table 21- Different glicemia interval and ANS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In table 22, it can be verified that the healthy participants with different glucose value 
do not present any significance statistical (p>0.05) independence for regions of the VS. And 
the diabetics participants have presented statistical significance in regions V1L, V3R, V4R, 
V5R and V6R of the VS 
 Healthy 
Participants 
Diabetic 
Participants 
 
ROIs of ANS 
p p 
N1L 0.12 0.26 
N1R 0.16 0.10 
N1S 0.05 0.98 
N2L 0.33 0.27 
N2R 0.16 0.09 
N2S 0.08 0.86 
N3L 0.33 0.19 
N3R 0.83 0.31 
N3S 0.13 0.64 
N4+5L 0.39 0.10 
N4+5R 0.34 0.04 
N4+5S 0.34 0.59 
N6L 0.57 0.26 
N6R 0.31 0.11 
N6S 0.57 0.21 
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Table 22- Different glicemia interval and VS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.3. Different BMI classification 
 
Two of the variables collected during this study were the height and weight of each 
participant. These two values were useful to calculate the body mass índex (equation 1). 
After this calculus, participants were included in a BMI classification, 18.5<25, 25<30, 30<35 
or ≥35. 
Analysis of significance of the BMI classification through the Kruskal-Wallis test based in 
the comparison of the mean temperature in ROIs of ANS and VS is shown in Tables 23 and 24. 
 Healthy 
participants 
Diabetic 
Participants 
 
ROIs of VS 
p p 
V1L 0.20 0.02 
V1R 0.21 0.06 
V1S 0.21 0.53 
V2L 0.18 0.19 
V2R 0.16 0.09 
V2S 0.19 0.69 
V3L 0.19 0.06 
V3R 0.19 0.02 
V3S 0.05 0.09 
V4L 0.23 0.15 
V4R 0.17 0.01 
V4S 0.54 0.64 
V5L 0.19 0.16 
V5R 0.24 0.02 
V5S 0.11 0.93 
V6L 0.55 0.21 
V6R 0.45 0.02 
V6S 0.20 0.79 
V7L 0.23 0.28 
V7R 0.30 0.14 
V7S 0.77 0.19 
V8L 0.34 0.43 
V8R 0.23 0.09 
V8S 0.37 0.53 
V9L 0.36 0.37 
V9R 0.85 0.37 
V9S 0.11 0.60 
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In table 23, it can be verified that for the healthy participants with different BMI 
classification do not present any significance statistical (p>0.05) of independence for regions 
of the ANS. And the diabetics participants have presented statistical significance (p<0.05) in 
regions N1R, N2R, N4+5R and N6R of the ANS.  
 
 
Table 23- Different BMI classification and ANS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In table 24, it can be verified that the healthy participants with different BMI 
classification do not present any statistical significance (p>0.05) of independence for regions 
of the VS. And the diabetics participants have presented statistical significance (p<0.05) of 
independence for the regions V2R, V3R, V4R, V5R, V6R, V7R and V8R of the VS.  
 
 
 
 
 
 
 
 
 Healthy 
Participants 
Diabetic 
Participants 
 
ROIs of ANS 
p p 
N1L 0.50 0.44 
N1R 0.97 0.02 
N1S 0.14 0.91 
N2L 0.74 0.45 
N2R 0.93 0.01 
N2S 0.51 0.88 
N3L 0.56 0.40 
N3R 0.75 0.10 
N3S 0.68 0.63 
N4+5L 0.65 0.23 
N4+5R 0.84 0.02 
N4+5S 0.13 0.82 
N6L 0.29 0.28 
N6R 0.79 0.02 
N6S 0.89 0.79 
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Table 24- Different BMI classification and VS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.4. Different age group 
 
Other variable that was collected during the study was the participants age, and 
depending on its value was included in a age group (18-29, 30-39, 40-49, 50-59, 60-69, ≥70 
years).  
Analysis of significance of the age group through the Kruskal-Wallis test based in the 
comparison of the mean temperature in ROIs of ANS and VS is shown in Tables 25 and 26. 
 Healthy 
participants 
Diabetic 
Participants 
 
ROIs of VS 
p p 
V1L 0.48 0.32 
V1R 0.66 0.21 
V1S 0.40 0.40 
V2L 0.90 0.42 
V2R 0.90 0.02 
V2S 0.78 0.75 
V3L 0.70 0.43 
V3R 0.63 0.02 
V3S 0.16 0.95 
V4L 0.62 0.75 
V4R 0.65 0.03 
V4S 0.68 0.35 
V5L 0.69 0.58 
V5R 0.36 0.04 
V5S 0.37 0.55 
V6L 0.84 0.42 
V6R 0.68 0.03 
V6S 0.92 0.96 
V7L 0.66 0.36 
V7R 0.89 0.02 
V7S 0.19 0.60 
V8L 0.36 0.48 
V8R 0.87 0.01 
V8S 0.04 0.53 
V9L 0.71 0.44 
V9R 0.95 0.14 
V9S 0.55 0.91 
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In table 25, it can be verified that both groups of healthy and diabetics participants with 
different age groups  do not present any statistical significance (p>0.05) of independence for 
regions of the ANS.  
 
Table 25- Different age groups and ANS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In table 26, it can be verified that healthy participants with different age groups do not 
present any statistical significance (p>0.05) of independence for regions of the VS. And the 
diabetics participants have statistical significance (p<0.05) of independence for regions V1L,  
V3R,V4R, V5R and V6R of the VS.  
 
 
 
 
 
 
 
 
 
 
 
 Healthy 
Participants 
Diabetic 
Participants 
 
ROIs of ANS 
p p 
N1L 0.23 0.11 
N1R 0.23 0.48 
N1S 0.19 0.57 
N2L 0.18 0.17 
N2R 0.24 0.45 
N2S 0.23 0.66 
N3L 0.83 0.08 
N3R 0.83 0.16 
N3S 0.60 0.27 
N4+5L 0.39 0.12 
N4+5R 0.39 0.54 
N4+5S 0.73 0.57 
N6L 0.36 0.18 
N6R 0.34 0.31 
N6S 0.13 0.44 
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Table 26- Different age groups and VS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4. Thermal symmetry 
 
According to the literature, it was confirmed that the lower limbs of the human body 
have a thermal symmetry (|thermal symmetry|≤0,5) [67, 68]. This crucial information allows 
a greater understanding and better identification of foot injuries. Therefore thermal 
symmetry, calculated through the equation 2 (chapter 3), was studied for the feet of healthy 
individuals and compared with diabetic individuals. This information is presented in figures 22 
and 23, in which it can be observed that for both systems (autonomic nervous system and 
 Healthy 
participants 
Diabetic 
Participants 
 
ROIs of VS 
p p 
V1L 0.20 0.02 
V1R 0.21 0.06 
V1S 0.21 0.53 
V2L 0.18 0.19 
V2R 0.16 0.09 
V2S 0.19 0.69 
V3L 0.19 0.06 
V3R 0.19 0.02 
V3S 0.05 0.09 
V4L 0.23 0.15 
V4R 0.17 0.01 
V4S 0.54 0.64 
V5L 0.19 0.16 
V5R 0.24 0.02 
V5S 0.11 0.93 
V6L 0.55 0.21 
V6R 0.45 0.02 
V6S 0.20 0.79 
V7L 0.23 0.28 
V7R 0.30 0.14 
V7S 0.77 0.19 
V8L 0.34 0.43 
V8R 0.23 0.09 
V8S 0.37 0.53 
V9L 0.36 0.37 
V9R 0.85 0.37 
V9S 0.11 0.60 
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vascular system) healthy individuals exhibit thermal symmetry, opposite to diabetics who 
have very different temperatures on the feet. 
 
 
 
 
 
 
 
 
 
 
Figure 22- Thermal symmetry for ANS.  
  
 
 
 
 
 
 
 
 
 
 
Figure 23- Thermal symmetry for VS. 
 
This huge discrepancy between the values of thermal symmetry between healthy 
individuals and diabetics, it can be easily observed through the figure 24. The thermal images 
A and B are of healthy individuals where it can be noticed the symmetrical pattern. Thermal 
Images C and D are of individuals with diabetic foot injuries, which exhibit marked 
differences in symmetry patterns, due to ulcers resulting from diabetes. 
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Figure 24– Thermal images of healthy individuals (A and B). Thermal images of individuals with diabetic 
foot (C and D). 
 
 
4.5. Follow-up 
 
Due to the severity of diabetic foot lesions, follow-up and constant monitoring of patients 
treatment is necessary. The values of thermal symmetry are an important parameter to 
assess the progression of lesions identified and adjust the respective treatment. 
To corroborate that thermography is an ideal monitoring method, the values of thermal 
symmetry for a follow-up of a patient, that has been followed for 3 weeks, is presented in 
figure 25, it can be observed that the patient has presented an improvement from his injury 
in the second week and a slight increase in the third week. 
 
 
 
Figure 25- Results of thermal symmetry during a 3 weeks follow-up of a diabetic patient. 
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4.5. Summary 
 
 
In the baseline diabetic patients presented higher mean temperature (approximately 3°C)  
in the ROIs of both systems when compared to healthy participants. A cold stimulus provoked 
a greater decrease of mean temperature in ANS and VS systems for healthy participants than 
for diabetic participants. Medial foot regions present more significance statistical  when 
compared the mean temperature ROIs of autonomous nervous and vascular systems. Glicemia 
interval, BMI classification and age group may be predictors of statistical signficance between 
ANS and VS regions of interest. 
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Chapter 5 
Discussion  
 
In the last decades considerable progress has been made in the performance of infrared 
imaging, equipment, standardisation of technique and clinical protocols for thermal imaging. 
This improvements were useful for a better understanding about physiological 
mechanisms and of temperature distribution on the body surface, allowing a wider aceptance 
of thermography by the health professionals. 
A methodology for studing surface skin temperature of the plantar feet was designed, 
implemented and assessed. ROIs have been defined for characterize the autonomous nervous 
and vascular systems in the plantar feet. These ROIs where useful for characterizing the 
temperature distribution, identify healthy controls and diabetic patients, distinguish 
diferente ulcer type and the influence of the characteristics that influence the pathology. 
However, despite all the care taken, thermal images capture in CHP showed values of 
mean humidity superior to adequate (humidity>50%). Despite this not being an impediment to 
image capture, it is important to consider because it can be a source of error. 
To study and characterize the temperature of the foot, a cold stimulus was applied to the 
feet of the participants, in order to provoke an imbalance in the feet temperature and study 
its physiological response. 
In the first moment diabetic patients presented higher mean temperature in the ROIs of 
both systems when compared to healthy participants. Inflammation in the feet associated 
with diabetic foot pathology can cause this fairly significant difference (approximately 3°C 
between healthy and diabetic for ANS and VS) in mean temperature. 
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Through the detailed analysis of the mean temperatures of the ROIs of autonomous 
nervous system, it is verified that healthy and diabetic individuals have a lower temperature 
for the sural area of the foot (N1) and for a higher temperature for saphenous area (N6). 
 In mean temperature of the ROIs of vascular system, it is verified that healthy and 
diabetic participants have a lower temperature for the second metatarsal of the foot (V2) 
and higher temperature in medial region of the foot (V7). 
This difference in temperatures for the aforementioned ROIs is due to the fact that the 
source of foot blood irrigation is closer in some regions, such as N6 and V7 that are medial 
plantar regions than others, such as N1 and V2, that are also areas of greater thermal energy 
release, which can lead to a lower mean temperature. 
After application of a cold stimulus during 2 minutes, is was verified that there was a 
mean temperature decrease of 1.1°C for healthy individuals and 0.4 to 0.6°C for diabetic 
individuals. This decrease of temperature is not very noticeable, because the used fan had 
little power and the affected area was not covered equally. 
Diminuishing the  temperature of the feet was not constant for all areas, however, both 
groups of healthy and diabetic subjects have a greater cooling to the ROIs corresponding to 
medial area of foot (N6 for the autonomous nervous system and V7 in vascular system). This 
areas are most sensible to temperature variation due the fact that have higher blood 
irrigation. 
In the third moment, in order to understand the responsiveness of temperature recovery 
after an imbalance caused by the cold stimulus, the healthy participants experienced a mean 
temperature increase of  about 0.1-0.2°C in relation to the previous moment, and the 
temperature of the feet of diabetic individuals increased approximately 0.5°C.  
The ROIs of healthy subjects where the highest occured was the N6 in the autonomous 
nervous system and V7 of vascular system. Diabetic individuals had a greater temperature 
increase in N6 and V6 for autonomic nervous and vascular systems, respectively. This ROIs are 
located in the inner region of the plantar feet, which is closer either to the main blood and 
nervous sources. 
After studying the relationship of the mean temperature foot ROIs between individuals 
with different types of diabetic foot lesion (neuropathic, ischaemic and neuroischaemic), it 
was concluded that there was no statistical evidence of a direct relationship between the 
ROIs temperature and the type of ulcer. However, this may be, due to several factors, such 
as the sample dimension. Another limitation of this study was the impossibility of applying a 
cold stimulus in a large part of diabetic individuals, due to practical constraints in the 
collection site, and it has limited the study in their physiologic response over three stages. 
This study was pioneer in characterizing the planar foot temperature distribution in two 
separate physiological systems of the diabetic foot, and in relating it with several variables.  
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Through the analysis of the several ROIs mean temperature for the autonomous nervous 
and vascular systems for diabetic individuals with type 1 or type 2 diabetes, there was only 
found a statistical significance in two regions (N4+5 of autonomic nervous system and V1 of 
vascular system). Within 15 studied ROIs, it was only found statistical evidence in two, those 
to ROIs are located in the region of the hallux, which is one of the most affected areas with 
the studied condition, for a better conclusion in the other ROIs, a larger sample and a 
thermal stimulus is advised. 
Since, continuous monitoring of blood glucose values in diabetics is a relevant procedure 
to have it controlled within the suitable range, to prevent diabetes progression and all its 
complications associated. With this characteristic, for the diabetic patients it was found 
statistical significance in the medial region (N4+5) of autonomous nervous system and in first, 
third, forth, fifth and arcuate foot regions (V1, V3, V4, V5 and V6) of vascular system. This 
can be explained by the associated ROIs with the condition and the glicemia interval being 
one of the most affect areas with ulcers, since it is close to the blood and nervous branches 
to the toes. For healthy individuals, it was not found any statistical evidence for any region of 
interest in both physiological systems. However, since the blood glucose value was not 
measured under the same conditions for all individuals (fasting period), that can be a bias. 
Regarding the relation with body mass index, it was found that this variable was not 
statistically significant for healthy participants in both physiological systems, however it is 
statistically significant in diabetic patients in all regions of the autonomous nervous system, 
and all regions of vascular system excluding the V1 and V9. These findings, indicate that the 
the body mass index is an important factor when studied the temperature of the feet of 
diabetic individuals. Moreover, a high value of BMI is a risk factor for diabetes and other 
health complications. 
The relationship with age group and condition did not present statistical significance with 
health participants. For diabetic patients, no statistical evidence was found for any regions of 
autonomic nervous system. For the vascular system it was found statistical significance in the 
V1, V3, V4, V5 and V6 regions. This may indicate that age might be a predictor of the 
temperature difference for the foot ROIs close to the blood and nervous branches that feed 
the toes, already mentioned as an high risk area for diabetic foot disease. Age brings an 
enormous panoply of complications such as longer period of disease, vascular problems, more 
difficulties in people keeping healthy habits, hygiene and self-care issues, becoming and 
important factor to take into consideration in the development of diabetic foot. 
In this study sample most of the affected patients revealed a higher incidence of diabetic 
foot in the right limb than in the other, which explains the obtained results per region having 
a greater tendency to the right side.  
Thermal symmetry is a fundamental indicator of the state of health of individuals. In the 
present study the thermal symmetry was used to corroborate with previous studies, in which 
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|thermal symmetry|≤ 0.5°C when compared the difference temperature between left and 
right foot [67,68]. This indicator confirmed the presence of pathology in the diabetic 
patients. 
Constant monitoring of individuals with diabetic foot ulcers is essential for monitoring the 
state of injury and if needed adjust treatment. Through the monitoring of a patient in CHP, it 
was possible to verify the progression of its treatment. Thus, thermography presents itself as 
a efficient tool for monitoring since it causes no harm to the patients and allows the tracking 
of patients over a long period of time without any injurious effect in them Being a tool that 
allows a real time analysis it can have a important diagnostic information during the patient 
appointment and also help clinicians to decide about the viability of the tissue in an 
amputation decision. 
Thermal imaging needs to evaluate in some technological aspects such as software, since 
there is no standard image format or capture and analysis software, having the analysis being 
performed in a manual way. 
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Chapter 6 
Conclusion  
The aim of this research project was to develop a methodology for characterizing the skin 
temperature of the plantar feet in diabetic foot patients. It was completely fulfilled, a 
capture analysis protocol was designed, implemented and assessed.  
Static and dynamic reference values of the plantar feet from a healthy population were 
provided. A thermal stimulus method was investigated and a relation between several 
characteristics that could affect the diabetic foot were explored and identified along with 
the proposed methodology.  
The main findings of this research project were: 
In the baseline diabetic patients presented higher mean temperature (approximately 3°C)  
in the ROIs of autonomous nervous and vascular systems when compared to healthy 
participants. A cold stimulus provoked a greater decrease of mean temperature in ANS and VS 
systems for healthy participants than for diabetic participants.  
Medial foot regions present more statistical significance when compared the mean 
temperature ROIs of autonomous nervous and vascular systems.  
Glicemia interval, BMI classification and age group may be predictors of statistical 
signficance between ANS and VS regions of interest. 
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6.1 Proposed future work 
 
In order to take this work into a next stage, the following future work is proposed: 
 
 Apply this methodology in a larger dimension experiment, to obtain more reliable results. 
 Develop an efficient cold stimulus for better understanding of the thermophysiology of the 
diabetic feet and associated characteristics. 
 Development of a dedicated software for standardizing the image analysis in order to 
improve the reproducibility and accuracy of the method. 
 Investigate indicators such as thermal symmetry for diabetic foot treatments assessment. 
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APPENDIX B  
 
 
 
 
   
 
TERMO DE CONSENTIMENTO INFORMADO 
 
Título do estudo de investigação: Diabetic foot thermophisiology characterization 
 Eu, abaixo-assinado (Nome completo do indivíduo participante do 
estudo):______________________________________________________________ 
 
 Fui informado de que o Estudo de Investigação acima mencionado se destina a 
investigar a utilização da termografia médica na avaliação fisiológica tanto na identificação 
precoce, como na avaliação dos tratamentos aos doentes com pé diabético. 
Sei que neste estudo está prevista a realização de um questionário e posterior recolha de 
imagens térmicas, tendo-me sido explicado em que consiste e quais os seus possíveis efeitos. 
 Foi-me garantido que todos os dados relativos à identificação dos Participantes neste 
estudo são confidenciais e que será mantido o anonimato. 
 Sei que posso recusar-me a participar ou interromper a qualquer momento a 
participação no estudo, sem nenhum tipo de penalização por este facto. 
 Compreendi a informação que me foi dada, tive oportunidade de fazer perguntas e as 
minhas dúvidas foram esclarecidas. 
 Aceito participar de livre vontade no estudo acima mencionado.  
 Também autorizo a divulgação dos resultados obtidos no meio científico, garantindo o 
anonimato. 
 
Nome do Participante no estudo  
Data      Assinatura 
      ___/___/_____   _________________________________________ 
 
Nome do Investigador Responsável  
Data      Assinatura 
      ___/___/_____   _________________________________________ 
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APPENDIX C  
 
INQUÉRITO AOS VOLUNTÁRIOS 
 
Data de realização do inquérito: __/__/_____ 
Género:     Masculino    Feminino  Outro 
Data de nascimento: __/__/_____ 
Peso: _____ (kg)      
Altura: _____ (m) 
Lesões ou cirurgias realizadas nos últimos meses:      Não             Sim   
Índice de glicose: ________ 
 
 
 
1. Possui alguma destas condições crónicas? 
  Diabetes tipo 1        Diabetes tipo 2      Diabetes gestacional    
 
2. Possui uma máquina para medir o nível de açúcar no sangue (glucose)? 
  Não        Sim 
 
3. Com que frequência faz o teste para medir o nível de açúcar no sangue? 
 Quase nunca FrequentementeDiariamente
 
 
 
1. Na última semana tomou comprimidos para a diabetes?  
  Não        Sim      Não sei 
Especifique o(s) nome(s) dos comprimidos que tomou:  ________________________________ 
HISTÓRICO 
MEDICAÇÃO 
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2. Na última semana tomou injecções de insulina? 
  Não        Sim      Não sei 
 
 
 
1. Em geral, como classifica a sua saúde: 
 
  Muito Debilitada   Debilitada   Razoável   Boa   Excelente 
 
2. Possui ou já possuiu alguma lesão nos pés devido à condição crónica (diabetes)  que 
apresenta? 
 
  Não        Sim 
Quais? (por exemplo, infecções na pele, fissuras, micoses)   
____________________________________________________________________ 
 
 
3. Apresenta falta de sensibilidade nos pés? 
  Não        Sim 
 
Caso a resposta seja afirmativa, indique qual das seguintes opções melhor descreve melhor 
a sua situação. 
Falta de sensibilidade leve               Falta de sensibilidade moderada  
 Falta de sensibilidade intensa 
 
 
4. Já teve de amputar algum dedo do pé, devido a complicações resultantes de lesões, mais 
comumente denominadas de “pé diabético”? 
 
  Não        Sim 
Se sim, assinale na figura qual dedo sofreu amputação: 
 
 
CONDIÇÃO DE SAÚDE 
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5. Assinale para cada uma das seguintes questões, a resposta que melhor descreve o seu 
estado de saúde. 
 
Mobilidade  
Não tenho qualquer problema em relação à minha mobilidade                                               
Tenho alguns problemas em relação à minha mobilidade                                                        
Tenho muitos problemas de mobilidade, e necessito de ajuda externa                            

Cuidados pessoais  
Não tenho qualquer problema para em realizar os meus cuidados pessoais                        
Tenho algumas dificuldades ao vestir-me e com os cuidados de higiene                        
Sou incapaz de vestir-me e ter cuidados de higiene sozinho                                        
 
Actividades diárias (por exemplo, trabalho, estudo, lides domésticas)  
Não tenho qualquer problemas ao realizar estas actividades                                       
Tenho  algumas dificuldades para realizar estas atividades                                          
Estou incapacitado de realizar estas atividades                                                          
 
Dor/Desconforto  
Não sinto qualquer dor ou desconforto                                                                    
Sinto alguma dor e desconforto                                                                                                     
Sinto dor e desconforto extremos                                                                                                 
 
 
6. Caso sinta dor ou desconforto assinale na escala seguinte, qual das seguintes opções 
descreve melhor a sua situação. 
 
Dor ou desconforto leve               Dor ou desconforto  moderado  
 Dor ou desconforto intenso 
 
 
 
1. Quando visita o seu médico, com que frequência apresenta este tipo de questões (circule o 
número que melhor se adequa às suas respostas). 
Nunca          Quase nunca       Às vezes       Muitas vezes         Sempre 
Prepara uma lista de questões/dúvidas  
para o seu médico                                               0                        1                      2                       3                        4  
 
CUIDADOS MÉDICOS 
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Faz questões sobre o seu tratamento ou 
 dúvidas relacionados com o mesmo               0                        1                      2                       3                        4  
Discute algum problema pessoal que pode  
estar relacionado com a sua doença                0                        1                      2                       3                        4  
 
 
2. Nos últimos 6 meses, quantas vezes visitou o seu médico? 
____________  vezes  
 
3. Nos últimos 6 meses quantas vezes recorreu aos serviços de urgência do hospital? 
____________  vezes  
 
4. Nos últimos 6 meses, quantas vezes esteve hospitalizado (uma noite ou mais)? 
____________  vezes  
 
5. Quantas vezes o médico ou enfermeiro analisou os seus pés nos últimos 6 meses? 
____________  vezes  
 
 
 
 
1. Em relação à sua qualidade de vida, circule o número que melhor se adequa à sua 
situação. 
 
Nunca          Quase nunca       Às vezes       Muitas vezes         Sempre 
Sente-se desencorajado/desanimado em  
relação ao seu problema de saúde                   0                        1                      2                       3                        4  
 
Tem medo em relação ao seu estado de  
saúde no futuro                                                    0                        1                      2                       3                        4  
 
A saúde é uma preocupação constante 
na sua vida                                                            0                        1                      2                       3                        4  
 
 
2. Para os doentes que possuem complicações graves derivadas da diabetes, como 
por exemplo, pé diabético, qual a sua opinião em relação à necessidade de 
implementar novos métodos de detecção e diagnóstico que não sejam dolorosos e 
invasivos para o paciente? 
 
  Discordo   Indiferente   Concordo     Acho extremamente importante 
 
Obrigado pela sua atenção!  
QUALIDADE DE VIDA 
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APPENDIX D 
 
PROTOCOLO DE TERMOGRAFIA 
 
Este protocolo é baseado no “Glamorgan Protocol”, uma referência para os 
procedimentos padrão recomendados para a recolha e avaliação de imagens térmicas em 
aplicações médicas. 
 
1. Localização para a recolha de imagens térmicas 
Sala de exames 
 Deve ser mantida uma distância mínima entre a câmara termográfica e o voluntário – 
normalmente 1 metro. A sala deve ter, no mínimo, 2x3 metros. 
 A sala deve conter apenas o material necessário para a recolha de imagens, de forma 
a evitar reflexões térmicas e criar artefactos nas imagens. 
 
Ambiente controlado 
 A sala deve ser mantida a uma temperatura constante entre 18-24°C, normalmente 
22±1°C, e será necessário que antes de iniciar a captura das imagens, que o 
voluntário permaneça na sala durante 15 minutos para que o seu corpo se mantenha 
em equilíbrio com a temperatura da sala. 
 Radiação ultravioleta deve ser evitada. Todas as janelas e portas devem ser 
devidamente fechadas. 
 A humidade relativa deve ser inferior a 50%. 
 A sala deve conter um equipamento de ar condicionado, de forma a manter a 
temperatura recomendada constante. O fluxo de ar proveniente do equipamento não 
deve ser orientado para o paciente. 
 O equipamento deve ser mantido fora da zona do voluntário, de modo a evitar 
perturbações. 
 Deve existir um cubículo mínimo na sala de exame, com as mesmas condições 
ambientais, para que o voluntário possa retirar/vestir as roupas com privacidade e 
descansar durante o período de aclimatização. 
 Não deve haver luz directamente incidida no voluntário, para evitar reflexões 
térmicas. 
 
2. Equipamento necessário 
O equipamento necessário para a recolha de dados será: 
- Câmara FLIR A325, para a captura das imagens de termografia. Esta câmara 
termográfica tem uma resolução real integrada de 320 x 240 pixels , a qual possui sensores 
que permite medir as temperaturas que variam entre -20°C a +120°C. Apresenta 
sensibilidade para detectar diferenças de temperatura menores que 0,08°C e possui exatidão 
de ± 2°C da temperatura absoluta.  
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- Oxímetro de pulso digital 50H – versão 1.0 (Micter®), dispositivo médico que mede 
indiretamente a quantidade de oxigénio no sangue de um paciente. 
- Tripé, para instalar e posicionar a câmara e ao nível dos pacientes. 
- FLIR Researcher Pro 2.10, software de análise de imagens infravermelhos. 
 
3. Cuidados para o equipamento termográfico 
 
 A câmara termográfica  deve ser ligada 40 minutos antes da captura de imagens. 
 O equipamento deve garantir um foco automático ou manual. 
 É recomendado o uso da temperatura externa como referência para a calibração, de 
modo a garantir a qualidade da imagem e sensibilidade da câmara. 
 O tipo de lentes da câmara deve ser considerado. Lentes com ângulos mais abertos 
reduzem a distância entre a câmara e o sujeito, mas ao mesmo tempo aumentam a 
distorção periférica da imagem. 
 O tripé para suporte da câmara deve evitar ângulos obtusos. 
 Cada imagem, ou conjunto de imagens deve indicar a gama de temperatura usada e o 
respectivo código de cor/ escala de temperaturas. A escala e gama de cores, 
comummente utilizado em aplicações médicas, varia entre 25°C e 37°C. 
 As temperaturas do fundo que podem diminuir a intensidade da imagem devem ser 
evitadas. As respectivas cores devem ser substituídas por branco, preto ou cinzento, 
de forma a conseguir uma melhor apresentação visual. 
 
4. Sujeito/Voluntário 
 
Informação para o voluntário 
 
O voluntário deve ser informado para: 
 Evitar o uso de aplicações tópicas: como o uso de ornamentos e maquilhagem no dia 
do exames. 
 Evitar grandes refeições e ingestão de café ou chá duas horas antes do exame. 
 Não fumar durante duas horas antes do exame. 
 Evitar o uso de roupas muito justas e apertadas. 
 Evitar a prática de exercício físico incluindo métodos de fisioterapia, como: 
electroterapia, ultra-sons, tratamento com calor, crioterapia, massagens e 
hidroterapia, nas últimas 6 horas antes do exame. 
 Evitar a ingestão de medicamentos, nomeadamente: esteróides, bloqueadores do 
sistema nervoso autónomo e medicações vasoactivas, opiáceos e autocolantes 
dérmicos, pelo menos 24 horas antes do exame. Excepções devem ser anotadas. 
 
Preparação pré-recolha 
 
 O voluntário deve ser informado sobre os procedimentos do exame, antes do seu 
início. 
 O voluntário deve ser instruído para retirar a roupa e os ornamentos. 
 O voluntário deve ser informado para sentar-se ou descansar na sala de exames no 
período de aclimatização. O período mínimo é de 10 minutos. 
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 O voluntário deve evitar contacto entre as partes do corpo, como dobrar ou cruzar 
braços e pernas. 
 Em casos de avaliação térmica dos membros inferiores, deve ser usado um apoio de 
forma a evitar o contacto direto com o chão. 
Posições para a recolha das imagens 
 O voluntário deve assumir posições corretas, de forma a serem adquiridas vistas 
padrão de regiões do corpo. 
 Alguma comparação/conclusão obtida em diferentes condições deve ser evitada. 
 
 
 
 
 
 
 
 
Figura 1 – Ilustração do posicionamento material necessário para a captura das 
imagens termográficas. A temperatura e a humidade da sala deve ser mantida dentro 
de um limite confortável, e a câmara deverá ser colocada perpendicular à superfície 
de observação para minimizar erros geométricos na medição da temperatura. 
 
Campo de visão 
 O voluntário deve conservar a distância mínima à câmara estabelecida, para que o 
campo de visão varie o mínimo possível. O tamanho da imagem está dependente 
desta distância e da distância focal da lente da câmara. 
 
 
 
 
 
 
 
 
 
 
 
 
A – Computador 
B – Câmara termográfica 
C – Tripé para suporte da câmara 
Ambiente controlado 
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APPENDIX E 
 
 
 
 
Table - Appendix A - Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for ANS 
ROIs temperatures in 2nd stage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of ANS 
U W Z p 
N1L 66.00 886.00 -4.23 0.00 
N1R 43.50 863.50 -4.67 0.00 
N1S 139.00 959.00 -2.80 0.01 
N2L 62.50 882.50 -4.30 0.00 
N2R 43.50 863.50 -4.67 0.00 
N2S 100.50 920.50 -3.56 0.00 
N3L 56.00 876.00 -4.43 0.00 
N3R 53.50 873.50 -4.47 0.00 
N3S 136.50 956.50 -2.85 0.00 
N4+5L 45.50 865.50 -4.63 0.00 
N4+5R 35.00 855.00 -4.84 0.00 
N4+5S 51.50 871.50 -4.52 0.00 
N6L 73.50 893.50 -4.08 0.00 
N6R 50.00 870.00 -4.54 0.00 
N6S 99.50 919.50 -3.59 0.00 
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Table - Appendix B - Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for VS 
ROIs temperatures in 2nd stage 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of VS 
U W Z p 
V1L 24.00 844.00 -5.06 0.00 
V1R 25.00 845.00 -5.04 0.00 
V1S 106.00 926.00 -3.46 0.00 
V2L 49.50 869.50 -4.55 0.00 
V2R 7.50 827.50 -5.38 0.00 
V2S 56.50 876.50 -4.44 0.00 
V3L 10.00 830.00 -5.33 0.00 
V3R 5.50 825.50 -5.42 0.00 
V3S 55.50 875.50 -4.47 0.00 
V4L 10.50 830.50 -5.32 0.00 
V4R 9.00 829.00 -5.35 0.00 
V4S 80.00 900.00 -3.98 0.00 
V5L 16.50 836.50 -5.20 0.00 
V5R 16.00 836.00 -5.21 0.00 
V5S 113.50 933.50 -3.31 0.00 
V6L 54.50 874.50 -4.45 0.00 
V6R 37.00 857.00 -4.80 0.00 
V6S 103.50 923.50 -3.50 0.00 
V7L 72.00 892.00 -4.11 0.00 
V7R 45.00 865.00 -4.64 0.00 
V7S 88.50 908.50 -3.81 0.00 
V8L 73.00 893.00 -4.09 0.00 
V8R 51.50 871.50 -4.51 0.00 
V8S 80.00 900.00 -3.97 0.00 
V9L 47.00 867.00 -4.60 0.00 
V9R 47.00 867.00 -4.60 0.00 
V9S 128.00 948.00 -3.02 0.00 
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APPENDIX F 
 
 
 
 
 
Table - Appendix C- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for ANS 
ROIs temperatures in 3rd stage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of ANS 
U W Z p 
N1L 74.00 894.00 -4.07 0.00 
N1R 34.00 854.00 -4.86 0.00 
N1S 118.50 938.50 -3.20 0.00 
N2L 62.50 882.50 -4.30 0.00 
N2R 36.50 856.50 -4.81 0.00 
N2S 77.00 897.00 -4.02 0.00 
N3L 47.50 867.50 -4.59 0.00 
N3R 46.00 866.00 -4.62 0.00 
N3S 141.50 961.50 -2.75 0.01 
N4+5L 51.00 871.00 -4.52 0.00 
N4+5R 47.50 867.50 -4.59 0.00 
N4+5S 92.50 912.50 -3.71 0.00 
N6L 77.50 897.50 -4.00 0.00 
N6R 51.00 871.00 -4.52 0.00 
N6S 59.50 879.50 -4.39 0.00 
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Table - Appendix D- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for VS ROIs 
temperatures in 3rd stage 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of VS 
U W Z p 
V1L 44.50 864.50 -4.65 0.00 
V1R 57.50 877.50 -4.39 0.00 
V1S 160.50 980.50 -2.37 0.02 
V2L 55.50 875.50 -4.43 0.00 
V2R 24.50 844.50 -5.04 0.00 
V2S 86.00 906.00 -3.86 0.00 
V3L 16.50 836.50 -5.20 0.00 
V3R 19.00 839.00 -5.15 0.00 
V3S 101.00 921.00 -3.56 0.00 
V4L 22.50 842.50 -5.09 0.00 
V4R 23.00 843.00 -5.08 0.00 
V4S 53.50 873.50 -4.50 0.00 
V5L 31.50 851.50 -4.91 0.00 
V5R 28.00 848.00 -4.98 0.00 
V5S 142.50 962.50 -2.73 0.01 
V6L 56.50 876.50 -4.41 0.00 
V6R 46.00 866.00 -4.62 0.00 
V6S 107.00 927.00 -3.43 0.00 
V7L 77.50 897.50 -4.00 0.00 
V7R 52.00 872.00 -4.50 0.00 
V7S 109.00 929.00 -3.40 0.00 
V8L 77.50 897.50 -4.00 0.00 
V8R 56.00 876.00 -4.42 0.00 
V8S 80.50 900.50 -3.95 0.00 
V9L 48.00 868.00 -4.58 0.00 
V9R 44.50 864.50 -4.65 0.00 
V9S 153.50 973.50 -2.51 0.01 
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APPENDIX G 
 
 
Table - Appendix E- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for ANS 
ROIs temperatures of partipants with neuropathic and neuroischaemic ulcers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of ANS U W Z p 
N1L 226.00 691.00 -0.94 0.35 
N1R 246.00 417.00 -0.51 0.61 
N1S 240.50 705.50 -0.63 0.53 
N2L 231.50 696.50 -0.82 0.41 
N2R 236.00 407.00 -0.72 0.47 
N2S 234.50 699.50 -0.76 0.45 
N3L 248.00 713.00 -0.47 0.64 
N3R 250.50 421.50 -0.42 0.68 
N3S 202.50 667.50 -1.44 0.15 
N4+5L 222.00 687.00 -1.02 0.31 
N4+5R 215.00 386.00 -1.17 0.24 
N4+5S 179.00 644.00 -1.94 0.05 
N6L 219.50 684.50 -1.08 0.28 
N6R 234.00 405.00 -0.77 0.44 
N6S 205.00 670.00 -1.39 0.17 
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Table - Appendix F- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for VS ROIs 
temperatures of partipants with neuropathic and neuroischaemic ulcers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of VS 
U W Z p 
V1L 243.50 708.50 -0.56 0.57 
V1R 224.00 395.00 -0.98 0.33 
V1S 215.50 680.50 -1.16 0.25 
V2L 239.50 704.50 -0.65 0.52 
V2R 230.50 401.50 -0.84 0.40 
V2S 176.50 641.50 -1.99 0.05 
V3L 260.50 725.50 -0.20 0.84 
V3R 265.50 436.50 -0.10 0.92 
V3S 236.50 701.50 -0.71 0.48 
V4L 258.50 723.50 -0.25 0.81 
V4R 254.50 425.50 -0.33 0.74 
V4S 186.50 651.50 -1.78 0.08 
V5L 265.00 730.00 -0.11 0.92 
V5R 258.00 429.00 -0.26 0.80 
V5S 201.50 666.50 -1.46 0.14 
V6L 247.00 712.00 -0.49 0.62 
V6R 255.50 426.50 -0.31 0.76 
V6S 195.50 660.50 -1.59 0.11 
V7L 231.50 696.50 -0.82 0.41 
V7R 251.50 422.50 -0.39 0.69 
V7S 213.00 678.00 -1.22 0.22 
V8L 222.00 687.00 -1.02 0.31 
V8R 239.50 410.50 -0.65 0.52 
V8S 243.00 414.00 -0.58 0.57 
V9L 241.50 706.50 -0.61 0.54 
V9R 253.00 424.00 -0.36 0.72 
V9S 213.50 678.50 -1.21 0.23 
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APPENDIX H 
 
 
 
Table - Appendix G- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test for ANS ROIs 
temperatures of partipants with ischaemic and neuroischaemic ulcers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of ANS U W Z p 
N1L 17.00 20.00 -0.13 0.90 
N1R 17.50 188.50 -0.06 0.95 
N1S 16.00 19.00 -0.25 0.80 
N2L 14.50 17.50 -0.44 0.66 
N2R 14.00 185.00 -0.50 0.61 
N2S 14.00 185.00 -0.51 0.61 
N3L 17.50 188.50 -0.06 0.95 
N3R 15.50 18.50 -0.32 0.75 
N3S 15.50 186.50 -0.32 0.75 
N4+5L 13.00 16.00 -0.63 0.53 
N4+5R 15.00 186.00 -0.38 0.71 
N4+5S 12.50 183.50 -0.69 0.49 
N6L 13.50 16.50 -0.57 0.57 
N6R 16.50 187.50 -0.19 0.85 
N6S 14.00 17.00 -0.51 0.61 
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Table - Appendix H- Mann Whitney U, Wilcoxon W Z and significancy of Mann Whitney test 
for VS ROIs temperatures of partipants with ischaemic and neuroischaemic ulcers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROIs of VS 
U W Z p 
V1L 10.00 13.00 -1.01 0.31 
V1R 16.00 187.00 -0.25 0.80 
V1S 17.00 20.00 -0.13 0.90 
V2L 12.00 15.00 -0.76 0.45 
V2R 17.00 20.00 -0.13 0.90 
V2S 15.00 18.00 -0.38 0.71 
V3L 8.00 11.00 -1.26 0.21 
V3R 17.00 188.00 -0.13 0.90 
V3S 10.00 181.00 -1.01 0.31 
V4L 5.00 8.00 -1.64 0.10 
V4R 13.00 184.00 -0.63 0.53 
V4S 6.00 177.00 -1.51 0.13 
V5L 11.00 14.00 -0.88 0.38 
V5R 16.50 19.50 -0.19 0.85 
V5S 15.00 18.00 -0.38 0.71 
V6L 13.00 16.00 -0.63 0.53 
V6R 12.00 183.00 -0.76 0.45 
V6S 7.50 178.50 -1.33 0.19 
V7L 12.50 15.50 -0.69 0.49 
V7R 15.50 18.50 -0.32 0.75 
V7S 15.00 18.00 -0.38 0.71 
V8L 16.50 19.50 -0.19 0.85 
V8R 14.00 185.00 -0.51 0.61 
V8S 16.00 187.00 -0.25 0.80 
V9L 16.50 187.50 -0.19 0.85 
V9R 14.50 17.50 -0.44 0.66 
V9S 15.00 186.00 -0.38 0.71 
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